Enhanced Investments - Financial Portal

Published: 2023-02-23


		CONSOLIDATED FINANCIAL STATEMENTS
MANAGEMENT’S RESPONSIBILITY FOR FINANCIAL REPORTING
The accompanying consolidated financial statements have been prepared by management and approved by the Board of Directors of the Company. The consolidated financial statements were prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board and, where appropriate, reflect management’s best estimates and judgments. Where alternative accounting methods exist, management has chosen those methods deemed most appropriate in the circumstances. Management is responsible for the accuracy, integrity and objectivity of the consolidated financial statements within reasonable limits of materiality, and for maintaining a system of internal controls over financial reporting as described in “Management’s annual report on internal control over financial reporting” included in Management’s Discussion and Analysis for the fiscal year ended January 1, 2023. Management is also responsible for the preparation and presentation of other financial information included in the 2022 Annual Report and its consistency with the consolidated financial statements.
The Audit and Finance Committee, which is appointed annual y by the Board of Directors and comprised exclusively of independent directors, meets with management as wel as with the independent auditors and internal auditors to satisfy itself that management is properly discharging its financial reporting responsibilities and to review the consolidated financial statements and the independent auditors’ report. The Audit and Finance Committee reports its findings to the Board of Directors for consideration in approving the consolidated financial statements for presentation to the shareholders. The Audit and Finance Committee considers, for review by the Board of Directors and approval by the shareholders, the engagement or reappointment of the independent auditors.
The consolidated financial statements have been independently audited by KPMG LLP, on behalf of the shareholders, in accordance with the standards of the Public Company Accounting Oversight Board (United States). Their report outlines the nature of their audit and expresses their opinion on the consolidated financial statements of the Company. In addition, our auditors have issued a report on the Company’s internal controls over financial reporting as of January 1, 2023. KPMG LLP has direct access to the Audit and Finance Committee of the Board of Directors.
(Signed: Glenn J. Chamandy)	(Signed: Rhodri J. Harries)
Glenn J. Chamandy	Rhodri J. Harries
President and Chief Executive	Executive Vice-President,
Officer	Chief Financial and Administrative
	Officer
February 21, 2023



		GILDAN 2022 REPORT TO SHAREHOLDERS 56

	CONSOLIDATED FINANCIAL STATEMENTS
KPMG LLP	Telephone	(514) 840-2100
600 de Maisonneuve Blvd. West	Fax	(514) 840-2187
Suite 1500, Tour KPMG	Internet	www.kpmg.ca
Montréal (Québec) H3A 0A3Canada
			REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
			To the Shareholders and Board of Directors of Gildan Activewear Inc.:
			Opinion on the Consolidated Financial Statements
			We have audited the accompanying consolidated statements of financial position of Gildan Activewear Inc. (the "Company") as of January 1, 2023 and January 2, 2022, the related consolidated statements of earnings and comprehensive income, changes in equity, and cash flows for the years ended January 1, 2023 and January 2, 2022, and the related notes (col ectively, the "consolidated financial statements"). In our opinion, the consolidated financial statements present fairly, in al material respects, the consolidated financial position of the Company as of January 1, 2023 and January 2, 2022 and its consolidated financial performance and its consolidated cash flows for the years ended January 1, 2023 and January 2, 2022, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.
			We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) ("PCAOB"), the Company’s internal control over financial reporting as of January 1, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 21, 2023 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.
			Basis for Opinion
			These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
			We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as wel as evaluating the overal presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
				KPMG LLP, an Ontario limited liability partnership and member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. KPMG Canada provides services to KPMG LLP.
					GILDAN 2022 REPORT TO SHAREHOLDERS 57

	CONSOLIDATED FINANCIAL STATEMENTS
Page 2
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especial y chal enging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Assessment and allocation of inventories costs
As discussed in Note 8 to the consolidated financial statements, the inventories balance as of January 1, 2023 was $1,225.9 mil ion, of which work in process and finished goods represented $974.2 mil ion. As discussed in Note 3(e) to the consolidated financial statements, inventories are stated at the lower of cost, determined on a first-in first-out basis, and net realizable value. As the Company manages its day-to-day production costs and inventories using a standard costing system, variances arise between these standard costs and the actual manufacturing costs. Adjustments are therefore required at period end to measure inventories at their actual cost. This involves accumulating manufacturing variances at each stage of the Company’s vertical y-integrated manufacturing process and identifying costs to be expensed immediately to cost of sales. Such costs include additional costs incurred as a result of operating below normal capacity and abnormal costs. The Company then applies a variance deferral factor, based primarily on the number of days of inventories on hand, to estimate the variances to be included in ending inventories. The determination of the variance deferral factor involves estimation. The combination of automated and non-automated systems and processes using data obtained from different geographical locations results in complexity in accumulation of manufacturing costs and in the identification of costs to be expensed immediately.
We identified the assessment of costs directly related to the conversion of raw materials to finished goods and the al ocation of manufacturing variances to the carrying value of inventories as a critical audit matter. A higher degree of auditor judgment and audit effort was required in testing the costs included in the carrying value of inventories and evaluating the variance deferral factor used in al ocating the manufacturing variances given the complexity of the process.The fol owing are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s inventory costing process, including controls related to: (1) identifying costs to be expensed immediately; and (2) establishing the variance deferral factor. We tested the eligibility of costs for recognition in inventories by: (1) assessing the nature of costs included in inventories by inspecting a sample of transactions recorded as manufacturing costs and tracing them to underlying documentation; (2) analyzing manufacturing variances to identify the existence of costs to be expensed immediately; and (3) assessing changes in production activity to identify costs to be expensed immediately. We assessed the variance deferral factor based on the number of days of inventory on hand determined by reference to the most recent past production, which included testing certain of the inputs to the calculation.
	GILDAN 2022 REPORT TO SHAREHOLDERS 58

		CONSOLIDATED FINANCIAL STATEMENTS
Page 3
Assessment of the carrying value of intangible assets in the Hosiery cash generating unit (“CGU”)
As discussed in Note 11 to the consolidated financial statements, the intangible asset balances as of January 1, 2023 in aggregate was $230.0 mil ion, of which $100.2 mil ion related to the Hosiery CGU. As discussed in Notes 3(j) and 3(dd) to the consolidated financial statements, the Company performs impairment testing on an annual basis or whenever events or changes in circumstances indicate that the carrying value of a CGU might exceed its recoverable amount, which is determined using the fair value less costs of disposal method. The Company’s assessment of the recoverable amount incorporates assumptions including estimated sales volumes, sel ing prices, input costs and sel ing, general and administrative ("SG&A") expenses in determining the risk adjusted forecasted recurring earnings before financial expenses, income taxes, depreciation and amortization, and restructuring and acquisition-related costs ("adjusted EBITDA") and the multiple applied to the adjusted EBITDA ("adjusted EBITDA multiple"). During the year ended January 1, 2023, the Company recorded an impairment charge of $62.3 mil ion in the Hosiery CGU.
We identified the assessment of the carrying value of intangible assets in the Hosiery CGU as a critical audit matter. There was a high degree of subjective auditor judgment required to evaluate the above noted assumptions used in determining the recoverable amount. The sensitivity of reasonably possible changes to those assumptions could have a significant impact on the determination of the recoverable amount of the Hosiery CGU and the Company’s recorded impairment charge in the Hosiery CGU as of January 1, 2023.
The fol owing are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s impairment assessment process, including controls related to (1) determining the adjusted EBITDA and the assumptions underlying its determination; and (2) identifying comparable peer companies and determining the adjusted EBITDA multiple. We evaluated the adjusted EBITDA for the Hosiery CGU by comparing the Company’s historical adjusted EBITDA forecasts to actual results and by examining the historical trend analysis of both increases and decreases in actual revenue, input costs and SG&A expenses as compared to the forecasted amounts. We chal enged the adjustments made to historical data by evaluating the reasonableness of adjustments through independent corroboration. We involved valuation professionals with specialized skil s and knowledge, who assisted in evaluating the adjusted EBITDA multiple used by the Company by comparing to publicly available EBITDA multiples for comparable entities
	.
We have served as the Company’s auditor since 1996.
Montréal, Canada
February 21, 2023
		GILDAN 2022 REPORT TO SHAREHOLDERS 59

	CONSOLIDATED FINANCIAL STATEMENTS
KPMG LLP	Telephone	(514) 840-2100
600 de Maisonneuve Blvd. West	Fax	(514) 840-2187
Suite 1500, Tour KPMG	Internet	www.kpmg.ca
Montréal (Québec) H3A 0A3Canada
			REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
			To the Shareholders and Board of Directors of Gildan Activewear Inc.
			Opinion on Internal Control Over Financial Reporting
			We have audited Gildan Activewear Inc.’s (the "Company") internal control over financial reporting as of January 1, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in al material respects, effective internal control over financial reporting as of January 1, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
			We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) ("PCAOB"), the consolidated statements of financial position of the Company as of January 1, 2023 and January 2, 2022, the related consolidated statements of earnings and comprehensive income, changes in equity, and cash flows for the years ended January 1, 2023 and January 2, 2022, and the related notes (col ectively, the consolidated financial statements), and our report dated February 21, 2023 expressed an unqualified opinion on those consolidated financial statements.
			Basis for Opinion
			The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying “Management’s annual report on internal control over financial reporting” included in Management’s Discussion and Analysis for the year ended January 1, 2023. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
			We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in al material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
				KPMG LLP, an Ontario limited liability partnership and member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. KPMG Canada provides services to KPMG LLP.
					GILDAN 2022 REPORT TO SHAREHOLDERS 60

	CONSOLIDATED FINANCIAL STATEMENTS
Page 2
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with general y accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with general y accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Montréal, Canada
February 21, 2023
	GILDAN 2022 REPORT TO SHAREHOLDERS 61


		CONSOLIDATED FINANCIAL STATEMENTS
GILDAN ACTIVEWEAR INC.
	CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(in thousands of U.S. dollars)
		January 1,		January 2,
			2023		2022
						Current assets:
						Cash and cash equivalents (note 6)	$	150,417		$	179,246
						Trade accounts receivable (note 7)		248,785			329,967
						Inventories (note 8)		1,225,940			774,358
						Prepaid expenses, deposits and other current assets		101,810			163,662
						Total current assets		1,726,952			1,447,233
						Non-current assets:
						Property, plant and equipment (note 9)		1,115,169			985,073
						Right-of-use assets (note 10(a))		77,958			92,447
						Intangible assets (note 11)		229,951			306,630
						Goodwil (note 11)		271,677			283,815
						Deferred income taxes (note 19)		16,000			17,726
						Other non-current assets		2,507		3,758
						Total non-current assets		1,713,262			1,689,449
						Total assets	$ 3,440,214		$ 3,136,682
						Current liabilities:
						Accounts payable and accrued liabilities	$	471,208		$	440,401
						Income taxes payable		6,637		7,912
						Current portion of lease obligations (note 10(b))		13,828			15,290
						Current portion of long-term debt (note 12)		150,000			—
						Total current liabilities		641,673			463,603
						Non-current liabilities:
						Long-term debt (note 12)		780,000			600,000
						Lease obligations (note 10(b))		80,162			93,812
						Other non-current liabilities (note 13)		56,217			59,862
						Total non-current liabilities		916,379			753,674
						Total liabilities		1,558,052			1,217,277
						Commitments, guarantees and contingent liabilities (note 24)Equity (note 14):
						Share capital		202,329			191,732
						Contributed surplus		79,489			58,128
						Retained earnings		1,590,499			1,604,736
						Accumulated other comprehensive income (note 15)		9,845		64,809
						Total equity attributable to shareholders of the Company		1,882,162			1,919,405
						Total liabilities and equity	$ 3,440,214		$ 3,136,682
						See accompanying notes to consolidated financial statements.
						On behalf of the Board of Directors:
						(Signed: Glenn J. Chamandy)	(Signed: Luc Jobin)
						Glenn J. Chamandy	Luc Jobin
						Director	Director
		GILDAN 2022 REPORT TO SHAREHOLDERS 62


						CONSOLIDATED FINANCIAL STATEMENTS
GILDAN ACTIVEWEAR INC.
	CONSOLIDATED STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME
		Fiscal years ended January 1, 2023 and January 2, 2022
		(in thousands of U.S. dollars, except per share data)
			2022	2021
					Net sales (note 27)	$	3,240,482	$	2,922,570
					Cost of sales (note 17(c))		2,248,070		1,982,361
					Gross profit		992,412				940,209
					Sel ing, general and administrative expenses (note 17(a))		324,108				314,171
					Impairment (Reversal of impairment) of trade accounts receivable (note 7)		2,150				(2,617)
					Restructuring and acquisition-related costs (note 18)		479				8,225
					Impairment of intangible assets (Impairment reversal of intangible assets, net of
					write-downs) (note 11)		62,290				(31,459)
					Operating income		603,385				651,889
					Financial expenses, net (note 15(c))		36,957				27,331
					Earnings before income taxes		566,428				624,558
					Income tax expense (note 19)		24,888				17,375
					Net earnings		541,540				607,183
					Other comprehensive (loss) income, net of related income taxes:
					Cash flow hedges (note 15(d))		(54,964)				73,847
					Actuarial gain (loss) on employee benefit obligations (note 13(a))		8,094				(21,678)
							(46,870)				52,169
					Comprehensive income	$	494,670			$	659,352
					Earnings per share (note 20):
					Basic	$	2.94			$	3.08
					Diluted	$	2.93			$	3.07
					See accompanying notes to consolidated financial statements.
						GILDAN 2022 REPORT TO SHAREHOLDERS 63


						CONSOLIDATED FINANCIAL STATEMENTS
GILDAN ACTIVEWEAR INC.
	CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
	Fiscal years ended January 1, 2023 and January 2, 2022
		(in thousands or thousands of U.S. dollars)
					Accumulated
			Share capital			other
				Contributed	comprehensive		Retained	Total
				surplus	income (loss)		earnings	Equity	Number			Amount
									Balance, January 3, 2021	198,407			$ 183,938	$	24,936	$	(9,038)	$ 1,359,061		$ 1,558,897
									Share-based compensation		—										—		37,526		—				—	37,526
									Shares issued under employee share
									purchase plan		41										1,406								—	—			—		1,406
									Shares issued pursuant to exercise of stock
									options		295										9,907		(1,753)		—				—	8,154
									Shares issued or distributed pursuant to
									vesting of restricted share units		132										2,762		(5,599)		—				—	(2,837)
									Shares repurchased for cancel ation
									(note 14(d))		(6,475)										(6,182)								—	—	(244,257)		(250,439)
									Share repurchases for settlement of non-
									Treasury RSUs (note 14(e))		(133)										(99)								—	—	(4,168)		(4,267)
									Deferred compensation to be settled in non-
									Treasury RSUs		—										—		2,075		—				—	2,075
									Dividends declared		—										—								943	—	(91,405)		(90,462)
									Transactions with shareholders of the
									Company recognized directly in equity		(6,140)										7,794		33,192		—		(339,830)		(298,844)
									Cash flow hedges (note 15(d))		—										—								—	73,847				—		73,847
									Actuarial gain on employee benefit
									obligations (note 13(a))		—										—								—	—	(21,678)		(21,678)
									Net earnings		—										—								—	—	607,183		607,183
									Comprehensive income		—										—								—	73,847		585,505		659,352
									Balance, January 2, 2022	192,267			$ 191,732	$	58,128	$	64,809		$ 1,604,736		$ 1,919,405
									Share-based compensation		—										—		32,248		—				—	32,248
									Shares issued under employee share
									purchase plan		48										1,568								—	—			—		1,568
									Shares issued pursuant to exercise of stock
									options		490										16,985		(3,440)		—				—	13,545
									Shares issued or distributed pursuant to
									vesting of restricted share units		229										5,556		(11,054)		—				—	(5,498)
									Shares repurchased for cancel ation
									(note 14(d))	(13,097)			(13,335)									—		—		(430,524)		(443,859)
									Share repurchases for settlement of non-
									Treasury RSUs (note 14(e))		(228)										(177)								—	—	(8,081)		(8,258)
									Deferred compensation to be settled in non-
									Treasury RSUs		—										—		2,110		—				—	2,110
									Dividends declared		—										—		1,497		—		(125,266)		(123,769)
									Transactions with shareholders of the
									Company recognized directly in equity	(12,558)										10,597		21,361		—		(563,871)		(531,913)
									Cash flow hedges (note 15(d))		—										—								—	(54,964)				—		(54,964)
									Actuarial loss on employee benefit
									obligations (note 13(a))		—										—								—	—	8,094		8,094
									Net earnings		—										—								—	—	541,540		541,540
									Comprehensive income		—										—								—	(54,964)		549,634		494,670
									Balance, January 1, 2023	179,709			$ 202,329	$	79,489	$	9,845	$ 1,590,499		$ 1,882,162
									See accompanying notes to consolidated financial statements.
						GILDAN 2022 REPORT TO SHAREHOLDERS 64


								CONSOLIDATED FINANCIAL STATEMENTS
GILDAN ACTIVEWEAR INC.
	CONSOLIDATED STATEMENTS OF CASH FLOWS
	Fiscal years ended January 1, 2023 and January 2, 2022
(in thousands of U.S. dollars)
		2022	2021
				Cash flows from (used in) operating activities:
				Net earnings	$ 541,540 $ 607,183
				Adjustments for: Depreciation and amortization (note 21)
					124,926 135,402
				Non-cash restructuring charges related to property, plant and equipment, right-of-use
						assets, and computer software (note 18)		(3,259)	3,136
				Impairment of intangible assets (Impairment reversal of intangible assets, net of write-
						downs) (note 11)		62,290	(31,459)
				Timing differences between settlement of financial derivatives and transfer of deferred
						gains or losses in accumulated OCI to inventory and net earnings		(11,253)	8,012
				(Gain) Loss on disposal of property, plant and equipment, including insurance
						recoveries		(34,195)	(43,660)
				Share-based compensation		32,393	37,659
				Other (note 22 (a))		8,140	(2,024)
				Changes in non-cash working capital balances (note 22 (c))	(307,094)	(96,739)
				Cash flows from operating activities	413,488 617,510
				Cash flows from (used in) investing activities:
				Purchase of property, plant and equipment	(239,128) (127,457)
				Purchase of intangible assets		(5,426)	(2,766)
				Business dispositions (acquisitions) (note 5)		33,543 (163,968)
				Proceeds from insurance related to property, plant and equipment (PP&E) and other
				disposals of PP&E		28,607 106,358
				Cash flows used in investing activities	(182,404) (187,833)
				Cash flows from (used in) financing activities:
				Increase in amounts drawn under revolving long-term bank credit facility	330,000	—
				Payment of term loan		— (400,000)
				Payment of lease obligations (note 10(b))		(16,559)	(21,474)
				Dividends paid	(123,769)	(90,462)
				Proceeds from the issuance of shares		14,968	9,427
				Repurchase and cancel ation of shares (note 14(d))	(449,158) (245,140)
				Share repurchases for settlement of non-Treasury RSUs (note 14(e))		(8,258)	(4,267)
				Withholding taxes paid pursuant to the settlement of non-Treasury RSUs		(5,498)	(2,837)
				Cash flows used in financing activities	(258,274) (754,753)
				Effect of exchange rate changes on cash and cash equivalents denominated in foreign
				currencies		(1,639)	(942)
				Net (decrease) increase in cash and cash equivalents during the fiscal year		(28,829) (326,018)
				Cash and cash equivalents, beginning of fiscal year	179,246 505,264
				Cash and cash equivalents, end of fiscal year	$ 150,417 $ 179,246
				Cash paid (included in cash flows from operating activities):
				Interest	$ 29,979 $ 22,201
				Income taxes, net of refunds		26,527	5,744
				Supplemental disclosure of cash flow information (note 22)See accompanying notes to consolidated financial statements.
								GILDAN 2022 REPORT TO SHAREHOLDERS 65

		NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal years ended January 1, 2023 and January 2, 2022 (Tabular amounts in thousands or thousands of U.S. dollars except per share data, unless otherwise indicated)
1. REPORTING ENTITY:
Gildan Activewear Inc. (the "Company" or "Gildan") is domiciled in Canada and is incorporated under the Canada Business Corporations Act. Its principal business activity is the manufacture and sale of activewear, hosiery and underwear. The Company's fiscal year ends on the Sunday closest to December 31 of each year.
The address of the Company’s registered office is 600 de Maisonneuve Boulevard West, Suite 3300, Montreal, Quebec. These consolidated financial statements are as at and for the fiscal years ended January 1, 2023 (fiscal 2022) and January 2, 2022 (fiscal 2021) and include the accounts of the Company and its subsidiaries. The Company is a publicly listed entity and its shares are traded on the Toronto Stock Exchange and New York Stock Exchange under the symbol GIL.
2. BASIS OF PREPARATION:
(a) Statement of compliance:
These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).
These consolidated financial statements for the fiscal year ended January 1, 2023 were authorized for issuance by the Board of Directors of the Company on February 21, 2023.
(b) Basis of measurement:
These consolidated financial statements have been prepared on the historical cost basis except for the fol owing items in the consolidated statements of financial position:•
	Derivative financial instruments which are measured at fair value;
•	Employee benefit obligations related to defined benefit plans which are measured at the present value of the defined benefit obligations, net of advance payments made to employees thereon;
•	Liabilities for cash-settled share-based payment arrangements which are measured at fair value, and equity-classified share-based payment arrangements which are measured at fair value at grant date pursuant to IFRS 2, Share-based payment;
•	Discontinued, damaged, and excess finished inventories which are carried at the net realizable value;
•	Provisions for decommissioning, site restoration costs, and onerous contracts which are measured at the present value of the expenditures expected to be required to settle the obligation; and
•	Identifiable assets acquired and liabilities assumed in connection with a business combination which are initial y measured at fair value.
These consolidated financial statements are presented in U.S. dol ars, which is the Company's functional currency.
			GILDAN 2022 REPORT TO SHAREHOLDERS 66

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2. BASIS OF PREPARATION (continued):
(c) Initial application of new or amended accounting standards:
During the year ended January 2, 2022, the Company adopted the fol owing new or amended accounting standards:
Interest Rate Benchmark ReformOn August 27 2020, the IASB published "Interest Rate Benchmark Reform - Phase 2 (Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16)" to address issues relating to the modification of financial assets, financial liabilities and lease liabilities, specific hedge accounting requirements, and disclosure requirements when an existing interest rate benchmark is actual y replaced. The amendment introduced a practical expedient for modifications required by the reform (modifications required as a direct consequence of the IBOR reform and made on an economical y equivalent basis). These modifications are accounted for by updating the effective interest rate. Al other modifications are accounted for using the current IFRS requirements. A similar practical expedient is available for interest rate reform for lessee accounting under IFRS 16. Under the amendments, hedge accounting is not discontinued solely because of the IBOR reform. Hedging relationships (and related documentation) must be amended to reflect modifications to the hedged item, hedging instrument, and hedged risk. Amended hedging relationships should meet al qualifying criteria to apply hedge accounting, including effectiveness requirements. The amendments are effective for annual reporting periods beginning on or after January 1, 2021 and are to be applied retrospectively. On March 25, 2022, the Company amended its unsecured revolving long-term bank credit facility and term loan to replace LIBOR references with Term Secured Overnight Financing Rate (‘ Term SOFR’ ). On June 30, 2022, the Company amended its notes purchase agreement to include LIBOR fal back provisions to replace LIBOR with adjusted term SOFR, adjusted daily simple SOFR or any relevant alternate rate selected by the note holders and the Company upon a benchmark transition event or early opt-in election. In addition, the Company and its counterparties under interest rate swap agreements are expected to negotiate the substitution of reference rates in such agreements. The Company applied the IFRS 9 interest rate benchmark reform practical expedient for amendments required by the interest rate reform to the revolving-long term bank credit facility, term loan and related interest rate swap agreements.
		GILDAN 2022 REPORT TO SHAREHOLDERS 67

		NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES:
The accounting policies set out below have been applied consistently to al periods presented in these consolidated financial statements, unless otherwise indicated.
(a) Basis of consolidation:
(i) Business combinations:
	Business combinations are accounted for using the acquisition method. Accordingly, the consideration transferred for the acquisition of a business is the fair value of the assets transferred and any debt and equity interests issued by the Company on the date control of the acquired company is obtained. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration arrangement. Contingent consideration classified as an asset or a liability that is a financial instrument is subsequently remeasured at fair value, with any resulting gain or loss recognized and included in restructuring and acquisition-related costs in the consolidated statement of earnings and comprehensive income. Acquisition-related costs, other than those associated with the issue of debt or equity securities, are expensed as incurred and are included in restructuring and acquisition-related costs in the consolidated statement of earnings and comprehensive income. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are general y measured initial y at their fair values at the acquisition date. The Company recognizes any non-control ing interest in an acquired company either at fair value or at the non-control ing interest’s proportionate share of the acquired company’s net identifiable assets. The excess of the consideration transferred over the fair value of the identifiable net assets acquired is recorded as goodwil . If the total of consideration transferred and non-control ing interest recognized is less than the fair value of the net assets of the business acquired, a purchase gain is recognized immediately in the consolidated statement of earnings and comprehensive income and applied as a reduction of restructuring and acquisition-related costs.
(i ) Subsidiaries:
	Subsidiaries are entities control ed by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. The accounting policies of subsidiaries are aligned with the policies adopted by the Company. Intragroup transactions, balances, and unrealized gains or losses on transactions between group companies are eliminated.
	The Company’s principal subsidiaries, their jurisdiction of incorporation, and the Company’s percentage ownership share of each are as fol ows:
		Jurisdiction of	Ownership
	Subsidiary	incorporation	percentage
	Gildan Activewear SRL			Barbados	100 %
	Gildan Yarns, LLC			Delaware	100 %
	Gildan USA LLC			Delaware	100 %
	Gildan Honduras Properties, S. de R.L.			Honduras	100 %
	Frontier Yarns, Inc.	North Carolina			100 %
	Gildan Activewear (UK) Limited	United Kingdom			100 %
	Gildan Activewear EU SRL			Belgium	100 %
	Gildan Textiles de Sula, S. de R.L.			Honduras	100 %
	G.A.B. Limited	Bangladesh			100 %
	SDS International Limited	Bangladesh			100 %
	Gildan Activewear Honduras Textile Company, S. de R.L.			Honduras	100 %
	Gildan Activewear (Eden) Inc.	North Carolina			100 %
	Gildan Hosiery Rio Nance, S. de R.L.			Honduras	100 %
	Gildan Mayan Textiles, S. de R.L.			Honduras	100 %
	Gildan Charleston Inc.			Delaware	100 %
	Gildan Activewear Dominican Republic Textile Company Inc.			Barbados	100 %
	Gildan Choloma Textiles, S. de R. L.			Honduras	100 %
		GILDAN 2022 REPORT TO SHAREHOLDERS 68

		NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(a) Basis of consolidation (continued):
(i ) Subsidiaries (continued):
	The Company has no other subsidiaries representing individual y more than 10% of the total consolidated assets and 10% of the consolidated net sales of the Company, or in the aggregate more than 20% of the total consolidated assets and the consolidated net sales of the Company as at and for the fiscal year ended January 1, 2023.
(b) Foreign currency translation:
Monetary assets and liabilities of the Company’s Canadian and foreign operations denominated in currencies other than the U.S. dol ar are translated using exchange rates in effect at the reporting date. Non-monetary assets and liabilities denominated in currencies other than U.S. dol ars are translated at the rates prevailing at the respective transaction dates. Income and expenses denominated in currencies other than U.S. dol ars are translated at average rates prevailing during the year. Gains or losses on foreign exchange are recorded in net earnings and presented in the statement of earnings and comprehensive income within financial expenses.
(c) Cash and cash equivalents:
The Company considers al liquid investments with maturities of three months or less from the date of purchase to be cash equivalents.
(d) Trade accounts receivable:
Trade accounts receivable consist of amounts due from our normal business activities. An al owance for expected credit losses is maintained to reflect an impairment risk for trade accounts receivable based on an expected credit loss model which factors in changes in credit quality since the initial recognition of trade accounts receivable based on customer risk categories. Expected credit losses are also provided for based on col ection history and specific risks identified on a customer-by-customer basis. Trade accounts receivable are presented net of al owances for expected credit losses, sales discounts, and sales returns when the Company has a right to offset the amounts.
The Company may continuously sel trade accounts receivables of certain designated customers to a third-party financial institution in exchange for a cash payment equal to the face value of the sold trade receivables less an applicable discount. The Company retains servicing responsibilities, including col ection, for these trade accounts receivables but does not retain any credit risk with respect to any trade accounts receivables that have been sold. Al trade accounts receivables sold under the receivables purchase agreement are removed from the consolidated statements of financial position, as the sale of the trade accounts receivables qualify for de-recognition. The net cash proceeds received by the Company are included as cash flows from operating activities in the consolidated statements of cash flows. The difference between the carrying amount of the trade accounts receivables sold under the agreement and the cash received at the time of transfer is recorded in the statement of earnings and comprehensive income within financial expenses.
			GILDAN 2022 REPORT TO SHAREHOLDERS 69

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(e) Inventories:
Inventories are stated at the lower of cost and net realizable value. The cost of inventories is based on the first-in, first-out principle, and reflect the various stages of production that inventories have reached at period-end. Inventory costs include the purchase price and other costs directly related to the acquisition of raw materials and spare parts held for use in the manufacturing process, and the cost of purchased finished goods. Inventory costs also include the costs directly related to the conversion of materials to finished goods, such as direct labour, and a systematic al ocation of fixed and variable production overhead, including manufacturing depreciation expense. The al ocation of fixed production overhead to the cost of inventories is based on the normal capacity of the production facilities. Additional costs incurred as a result of operating below the normal capacity of the production facilities are excluded from the carrying value of inventories and charged directly to cost of sales. Normal capacity is the average production expected to be achieved during the fiscal year, under normal circumstances. The Company manages its day-to-day production costs and inventories using a standard inventory costing system whereby the cost of a product is determined using pre-established rates for materials, labour and production overhead expenses based on the manufacturing specifications of the product. At period end, the Company assesses whether the variances between the standard costs and the actual costs incurred relate to the conversion of materials to finished goods, or if they represent abnormal costs that should be charged directly to cost of sales. The carrying value of inventories is then adjusted to record the manufacturing variances related to inventories stil on hand and manufacturing variances related to inventories that have been sold are charged to cost of sales, through an al ocation method which uses an estimated variance deferral factor based on the number of days of inventory on hand based on the most recent past production. The Company's inventory costing process involves a combination of automated and non-automated systems and processes using data obtained from different geographical locations. Net realizable value is the estimated sel ing price of finished goods in normal sales channels, or where applicable, liquidation channels, less the estimated costs of completion and sel ing expenses. Raw materials, work in progress, and spare parts inventories are not written down if the finished products in which they wil be incorporated are expected to be sold at or above cost.
(f) Assets held for sale:
Non-current assets which are classified as assets held for sale are reported in current assets in the statement of financial position, when their carrying amount is to be recovered principal y through a sale transaction rather than through continuing use, and a sale is considered highly probable. Assets held for sale are stated at the lower of their carrying amount and fair value less costs to sel .
(g) Property, plant and equipment:
Property, plant and equipment are initial y recorded at cost and are subsequently carried at cost less any accumulated depreciation and any accumulated impairment losses. The cost of an item of property, plant and equipment includes expenditures that are directly attributable to the acquisition or construction of an asset. The cost of self-constructed assets includes the cost of materials and direct labour, site preparation costs, initial delivery and handling costs, instal ation and assembly costs, and any other costs directly attributable to bringing the assets to the location and condition necessary for the assets to be capable of operating in the manner intended by management. The cost of property, plant and equipment also includes, when applicable, borrowing costs, as wel as the initial present value estimate of the costs of decommissioning or dismantling and removing the asset and restoring the site on which it is located at the end of its useful life which is amortized over the remaining life of the underlying asset. Purchased software that is integral to the functionality of the related equipment is capitalized as part of other equipment. Subsequent costs are included in an asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits are present and the cost of the item can be measured reliably. When property, plant and equipment are replaced they are ful y written down. Gains and losses on the disposal of an item of property, plant and equipment are determined by comparing the proceeds from disposal with the carrying amount of property, plant and equipment and are recognized in the statement of earnings and comprehensive income.
		GILDAN 2022 REPORT TO SHAREHOLDERS 70

		NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(g) Property, plant and equipment (continued):
Land is not depreciated. The cost of property, plant and equipment less its residual value, if any, is depreciated on a straight-line basis over the fol owing estimated useful lives:
Asset	Useful life
Buildings and improvements	5 to 40 years
Manufacturing equipment	2 to 20 years
Other equipment	3 to 10 years
(1) The majority of the Company's manufacturing equipment is depreciated over a 15 to 20 year period.
Significant components of plant and equipment which are identified as having different useful lives are depreciated separately over their respective useful lives. Depreciation methods, useful lives and residual values, if applicable, are reviewed and adjusted, if appropriate, on a prospective basis at the end of each fiscal year.
Assets not yet utilized in operations include expenditures incurred to date for plant constructions or expansions which are stil in process and equipment not yet placed into service as at the reporting date. Depreciation on these assets commences when the assets are available for use.
Borrowing costsBorrowing costs that are directly attributable to the acquisition or construction of a qualifying asset are capitalized as part of the cost of the asset. A qualifying asset is one that necessarily takes a substantial period of time to get ready for its intended use. Capitalization of borrowing costs ceases when the asset is completed and available for use. Al other borrowing costs are recognized as financial expenses in the consolidated statement of earnings and comprehensive income as incurred.
(h) Intangible assets:
Definite life intangible assets are measured at cost less accumulated amortization and any accumulated impairment losses. Intangible assets include identifiable intangible assets acquired and consist of customer contracts and customer relationships, license agreements, trademarks, and non-compete agreements. Intangible assets also include computer software that is not an integral part of the related hardware. Indefinite life intangible assets represent intangible assets which the Company controls which have no contractual or legal expiration date and therefore are not amortized as there is no foreseeable time limit to their useful economic life. An assessment of indefinite life intangible assets is performed annual y to determine whether events and circumstances continue to support an indefinite useful life and any change in the useful life assessment from indefinite to finite is accounted for as a change in accounting estimate on a prospective basis. Intangible assets with finite lives are amortized on a straight-line basis over the fol owing estimated useful lives:
Asset	Useful life
Customer contracts and customer relationships	7 to 20 years
License agreements	3 to 10 years
Computer software	4 to 7 years
Trademarks with a finite life	5 years
Non-compete agreements	2 years
Most of the Company's trademarks are not amortized as they are considered to be indefinite life intangible assets.
			GILDAN 2022 REPORT TO SHAREHOLDERS 71

		NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(h) Intangible assets (continued):
The costs of information technology projects that are directly attributable to the design and testing of identifiable and unique software products, including internal y developed computer software, are recognized as intangible assets when the fol owing criteria are met:
•	it is technical y feasible to complete the software product so that it wil be available for use;
•	management intends to complete the software product and use it;
•	there is an ability to use the software product;
•	it can be demonstrated how the software product wil generate probable future economic benefits;
•	adequate technical, financial, and other resources to complete the development and to use the software product are available; and
•	the expenditures attributable to the software product during its development can be reliably measured.
Other development expenditures that do not meet these criteria are recognized as an expense in the consolidated statement of earnings and comprehensive income as incurred.
(i) Goodwill:
Goodwil is measured at cost less accumulated impairment losses, if any. Goodwil arises on business combinations and is measured as the excess of the consideration transferred and the recognized amount of the non-control ing interest in the acquired business, if any, over the fair value of identifiable assets acquired and liabilities assumed of an acquired business.
(j) Impairment of non-financial assets:
Non-financial assets that have an indefinite useful life such as goodwil and trademarks are not subject to amortization and are therefore tested annual y for impairment or more frequently if events or changes in circumstances indicate that the asset might be impaired. Assets that are subject to amortization are assessed at the end of each reporting period as to whether there is any indication of impairment or whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset’s value in use and fair value less costs of disposal. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups of assets, in which case assets are grouped at the lowest levels for which there are separately identifiable cash inflows (i.e. cash-generating units or "CGUs").
In assessing value in use, the estimated future cash flows expected to be derived from the asset or CGU by the Company are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset and or the CGU. In assessing a CGU’s fair value less costs of disposal, the Company uses the best information available to reflect the amount that the Company could obtain, at the time of the impairment test, from the disposal of the asset or CGU in an arm’s length transaction between knowledgeable, wil ing parties, after deducting the estimated costs of disposal.
For the purpose of testing goodwil for impairment, goodwil acquired in a business combination is al ocated to a CGU or a group of CGUs that is expected to benefit from the synergies of the combination, regardless of whether other assets or liabilities of the acquired company are assigned to those CGUs. Impairment losses recognized are al ocated first to reduce the carrying amount of any goodwil al ocated to the CGU and then to reduce the carrying amounts of the other assets in the CGU on a pro rata basis. Impairment losses are recognized in the statement of earnings and comprehensive income.
Reversal of impairment lossesA goodwil impairment loss is not reversed. Impairment losses on non-financial assets other than goodwil recognized in prior periods are assessed at each reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed if there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized.
			GILDAN 2022 REPORT TO SHAREHOLDERS 72

			NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(k) Financial instruments:
The Company initial y recognizes financial assets on the trade date at which the Company becomes a party to the contractual provisions of the instrument. Financial assets are initial y measured at fair value. If the financial asset is not subsequently accounted for at fair value through profit or loss, then the initial measurement includes transaction costs that are directly attributable to the asset’s acquisition or origination. On initial recognition, the Company classifies its financial assets as subsequently measured at either amortized cost or fair value, depending on its business model for managing the financial assets and the contractual cash flow characteristics of the financial assets.
Financial assetsFinancial assets are classified into the fol owing categories and depend on the purpose for which the financial assets were acquired.
	Financial assets measured at amortized costA financial asset is subsequently measured at amortized cost, using the effective interest method and net of any impairment loss, if:
	•	The asset is held within a business model whose objective is to hold assets in order to col ect contractual cash flows; and
	•	The contractual terms of the financial asset give rise, on specified dates, to cash flows that are solely payments of principal and/or interest.
	The Company currently classifies its cash and cash equivalents, trade accounts receivable, certain other current assets (excluding derivative financial instruments designated as effective hedging instruments), and long-term non-trade receivables as financial assets measured at amortized cost. The Company de-recognizes a financial asset when the contractual rights to the cash flows from the asset expire, or it transfers the rights to receive the contractual cash flows on the financial asset in a transaction in which substantial y al the risks and rewards of ownership of the financial asset are transferred.
	Financial assets measured at fair valueThese assets are measured at fair value and changes therein, including any interest or dividend income, are recognized in profit or loss. However, for investments in equity instruments that are not held for trading, the Company may elect at initial recognition to present gains and losses in other comprehensive income. For such investments measured at fair value through other comprehensive income, gains and losses are never reclassified to profit or loss, and no impairment is recognized in profit or loss. Dividends earned from such investments are recognized in profit or loss, unless the dividend clearly represents a repayment of part of the cost of the investment. The Company currently has no significant financial assets measured at fair value other than derivative financial instruments.
	Fair value through other comprehensive income ("FVOCI")A debt investment is measured at FVOCI if it is not designated as at fair value through profit or loss, is held within a business model whose objective is achieved by both col ecting contractual cash flows and sel ing financial assets, and its contractual terms give rise to cash flows on specified dates that are solely payments of principal and interest on the principal amount outstanding. These assets are subsequently measured at fair value. Interest income calculated using the effective interest method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are recognized in other comprehensive income ("OCI"). On derecognition, gains and losses accumulated in OCI are reclassified to profit or loss. On initial recognition of an equity investment that is not held for trading, the Company may irrevocably elect to present subsequent changes in the investments fair value in OCI. This election is made on an investment by investment basis. These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never reclassified to profit or loss. The Company currently has no financial assets measured at FVOCI.
				GILDAN 2022 REPORT TO SHAREHOLDERS 73

		NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(k) Financial instruments (continued):
Financial liabilitiesFinancial liabilities are classified into the fol owing categories.
	Financial liabilities measured at amortized cost A financial liability is subsequently measured at amortized cost, using the effective interest method. The Company currently classifies accounts payable and accrued liabilities (excluding derivative financial instruments designated as effective hedging instruments), and long-term debt bearing interest at variable and fixed rates as financial liabilities measured at amortized cost.
	Financial liabilities measured at fair value Financial liabilities at fair value are initial y recognized at fair value and are remeasured at each reporting date with any changes therein recognized in net earnings. The Company currently has no significant financial liabilities measured at fair value.
The Company derecognizes a financial liability when its contractual obligations are discharged or cancel ed or expired.
Financial assets and liabilities are offset and the net amount presented in the statement of financial position when, and only when, the Company has a legal right to offset the amounts and intends either to settle on a net basis or to realize the asset and settle the liability simultaneously.
Fair value of financial instrumentsFinancial instruments measured at fair value use the fol owing fair value hierarchy to prioritize the inputs used in measuring fair value:•
	Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;
•	Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and
•	Level 3: inputs for the asset or liability that are not based on observable market data.
Impairment of financial assetsThe Company recognizes loss al owances for expected credit losses on financial assets measured at amortized cost. The Company recognizes a loss al owance at an amount equal to the lifetime expected credit losses if the credit risk on that financial instrument has increased significantly since initial recognition. Otherwise, the loss al owance for that financial instrument corresponds to an amount equal to twelve-month expected credit losses. The Company uses the simplified method to measure the loss al owance for trade receivables at lifetime expected losses. The Company uses historical trends of default, the timing of recoveries and the amount of loss incurred, adjusted for management’s judgement as to whether current economic and credit conditions are such that the actual losses are likely to be greater or less than suggested by historical trends. Losses are recognized in the consolidated statement of income and reflected in an al owance account against trade and other receivables.
(l) Derivative financial instruments and hedging relationships:
The Company enters into derivative financial instruments to hedge its market risk exposures. On initial designation of the hedge, the Company formal y documents the relationship between the hedging instruments and hedged items, including the risk management objectives and strategy in undertaking the hedge transaction, together with the methods that wil be used to assess the effectiveness of the hedging relationship. The Company makes an assessment, both at the inception of the hedge relationship as wel as on an ongoing basis, whether the hedging instruments are expected to be effective in offsetting the changes in the fair value or cash flows of the respective hedged items during the period for which the hedge is designated. For a cash flow hedge of a forecasted transaction, the transaction should be highly probable to occur and should present an exposure to variations in cash flows that could ultimately affect reported net earnings.
Derivatives are recognized initial y at fair value, and attributable transaction costs are recognized in net earnings as incurred. Subsequent to initial recognition, derivatives are measured at fair value, and changes therein are accounted for as described below.
			GILDAN 2022 REPORT TO SHAREHOLDERS 74

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(l) Derivative financial instruments and hedging relationships (continued):
Cash flow hedgesWhen a derivative is designated as the hedging instrument in a hedge of the variability in cash flows attributable to a particular risk associated with a recognized asset or liability or a highly probable forecasted transaction that could affect net earnings, the effective portion of changes in the fair value of the derivative is recognized in other comprehensive income and presented in accumulated other comprehensive income as part of equity. The amount recognized in other comprehensive income is removed and included in net earnings under the same line item in the consolidated statement of earnings and comprehensive income as the hedged item, in the same period that the hedged cash flows affect net earnings. When a hedged forecasted transaction subsequently results in the recognition of a non-financial asset or liability, the cash flow hedge reserve is removed from accumulated other comprehensive income and included in the initial cost or carrying amount of the asset or liability. Any ineffective portion of changes in the fair value of the derivative is recognized immediately in net earnings. If the hedging instrument no longer meets the criteria for hedge accounting, expires or is sold, terminated, exercised, or the designation is revoked, then hedge accounting is discontinued prospectively. If the forecasted transaction is no longer expected to occur, then the balance in accumulated other comprehensive income is recognized immediately in net earnings.
Fair value hedgesChanges in the fair value of derivatives that are designated and qualify as fair value hedges are recognized in net earnings, together with any changes in the fair value of the hedged asset, liability or firm commitment that are attributable to the hedged risk. The change in fair value of the hedging instrument and the change in the hedged item attributable to the hedged risk are recognized in the statement of earnings and comprehensive income or in the statement of financial position caption relating to the hedged item. If the hedging instrument no longer meets the criteria for hedge accounting, expires or is sold, terminated, exercised, or the designation is revoked, then hedge accounting is discontinued prospectively.
Embedded derivativesEmbedded derivatives within a financial liability are separated from the host contract and accounted for separately if the economic characteristics and risks of the host contract and the embedded derivative are not closely related, a separate instrument with the same terms as the embedded derivative would meet the definition of a derivative, and the combined instrument is not measured at fair value through profit or loss.
Other derivativesWhen a derivative financial instrument is not designated in a qualifying hedge relationship, al changes in its fair value are recognized immediately in net earnings.
(m) Accounts payable and accrued liabilities:
Accounts payable and accrued liabilities are recognized initial y at fair value and subsequently measured at amortized cost using the effective interest method. Accounts payable and accrued liabilities are classified as current liabilities if payment is due within one year, otherwise, they are presented as non-current liabilities.
(n) Long-term debt:
Long-term debt is recognized initial y at fair value and is subsequently carried at amortized cost. Initial facility fees are deferred and treated as an adjustment to the instrument's effective interest rate and recognized as an expense over the instrument's estimated life if it is probable that the facility wil be drawn down. However, if it is not probable that a facility wil be drawn down for its entire term, then the fees are considered service fees and are deferred and recognized as an expense on a straight-line basis over the commitment period.
		GILDAN 2022 REPORT TO SHAREHOLDERS 75

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(o) Employee benefits:
Short-term employee benefitsShort-term employee benefits include wages, salaries, commissions, compensated absences and bonuses. Short-term employee benefit obligations are measured on an undiscounted basis and are expensed as the related service is provided. A liability is recognized for the amount expected to be paid under short-term cash bonus or profit sharing plans if the Company has a present legal or constructive obligation to pay this amount as a result of past service provided by the employee, and the obligation can be estimated reliably. Short-term employee benefit obligations are included in accounts payable and accrued liabilities.
Defined contribution plansThe Company offers group defined contribution plans to eligible employees whereby the Company matches employees' contributions up to a fixed percentage of the employee's salary. Contributions by the Company to trustee-managed investment portfolios or employee associations are expensed as incurred. Benefits are also provided to employees through defined contribution plans administered by the governments in the countries in which the Company operates. The Company’s contributions to these plans are recognized in the period when services are rendered.
Defined benefit plansThe Company maintains a liability for statutory severance obligations for active employees primarily located in the Caribbean and Central America which is payable to the employees in a lump sum payment upon termination of employment. The liability is based on management’s best estimates of the ultimate costs to be incurred to settle the liability and is based on a number of assumptions and factors, including historical trends, actuarial assumptions and economic conditions. Liabilities related to defined benefit plans are included in other non-current liabilities in the consolidated statement of financial position. Service costs, interest costs, and costs related to the impact of program changes are recognized in cost of sales in the consolidated statement of earnings. Actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized directly to other comprehensive income in the period in which they arise, and are immediately transferred to retained earnings without reclassification to net earnings in a subsequent period.
(p) Provisions:
Provisions are recognized when the Company has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources wil be required to settle the obligation, and the amount can be reliably estimated. Provisions are not recognized for future operating losses. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognized as financial expense. Provisions are included in other non-current liabilities in the consolidated statement of financial position.
Decommissioning and site restoration costsThe Company recognizes decommissioning and site restoration obligations for future removal and site restoration costs associated with the restoration of certain property and plant should it decide to discontinue some of its activities.
Onerous contractsProvisions for onerous contracts are recognized if the unavoidable costs of meeting the obligations specified in a contractual arrangement exceed the economic benefits expected to be received from the contract. Provisions for onerous contracts are measured at the lower of the cost of fulfil ing the contract and the expected cost of terminating the contract.
		GILDAN 2022 REPORT TO SHAREHOLDERS 76

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(q) Share capital:
Common shares are classified as equity. Incremental costs directly attributable to the issuance of common shares and stock options are recognized as a deduction from equity, net of any tax effects.
When the Company repurchases its own shares, the consideration paid, including any directly attributable incremental costs (net of income taxes) is deducted from equity attributable to the Company’s equity holders until the shares are cancel ed or reissued. When the shares are cancel ed, the excess of the consideration paid over the average stated value of the shares purchased for cancel ation is charged to retained earnings.
(r) Dividends declared:
Dividends declared to the Company’s shareholders are recognized as a liability in the consolidated statement of financial position and charged to retained earnings in the period in which the dividends are approved by the Company’s Board of Directors.
(s) Revenue recognition:
The Company derives revenue from the sale of finished goods, which include activewear, hosiery, and underwear. The Company recognizes revenue at a point in time when it transfers control of the finished goods to a customer, which general y occurs upon shipment of the finished goods from the Company’s facilities. In certain arrangements, control is transferred and revenue is recognized upon delivery of the finished goods to the customer’s premises.
Some arrangements for the sale of finished goods provide for customer price discounts, rights of return and/or volume rebates based on aggregate sales over a specified period, which gives rise to variable consideration. At the time of sale, estimates are made for items giving rise to variable consideration based on the terms of the sales program or arrangement. The variable consideration is estimated at contract inception using the most likely amount method and revenue is only recognized to the extent that a significant reversal of revenue is not expected to occur. The estimate is based on historical experience, current trends, and other known factors. New sales incentive programs which relate to sales made in a prior period are recognized at the time the new program is introduced. Sales are recorded net of customer discounts, rebates, and estimated sales returns, and exclude sales taxes. A provision is recognized for expected returns in relation to sales made before the end of the reporting period.
Consideration payable to a customer that is not considered a distinct good or service from the customer, such as one-time fees paid to customers for product placement or product introduction, is accounted for as a reduction of the transaction price, and the Company recognizes the reduction of revenue at the later of when Company recognizes revenue for the transfer of the related goods to the customer or when the Company pays or promises to pay the consideration.
(t) Cost of sales and gross profit:
Cost of sales includes al raw material costs, manufacturing conversion costs, including manufacturing depreciation expense, sourcing costs, inbound freight and inter-facility transportation costs, and outbound freight to customers. Cost of sales also includes the cost of purchased finished goods, costs relating to purchasing, receiving and inspection activities, manufacturing administration, third-party manufacturing services, sales-based royalty costs, insurance, inventory write-downs, and customs and duties, as wel as net insurance gains as described in note 17 (c). Gross profit is the result of net sales less cost of sales. The Company’s gross profit may not be comparable to gross profit as reported by other companies, since some entities include warehousing and handling costs, and/or exclude depreciation expense, outbound freight to customers and royalty costs from cost of sales.
(u) Selling, general and administrative expenses:
Sel ing, general and administrative (“SG&A”) expenses include warehousing and handling costs, sel ing and administrative personnel costs, advertising and marketing expenses, costs of leased non-manufacturing facilities and equipment, professional fees, non-manufacturing depreciation expense, and other general and administrative expenses. SG&A expenses also include amortization of intangible assets.
		GILDAN 2022 REPORT TO SHAREHOLDERS 77

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(v) Restructuring and acquisition-related costs:
Restructuring and acquisition-related costs are expensed when incurred, or when a legal or constructive obligation exists. Restructuring and acquisition-related costs are comprised of costs directly related to significant exit activities, including the closure of business locations or the relocation of business activities, significant changes in management structure, as wel as transaction and integration costs incurred pursuant to business acquisitions. The nature of expenses included in restructuring and acquisition-related costs may include: severance and termination benefits, including the termination of employee benefit plans; gains or losses from the remeasurement and disposal of assets held for sale; write-downs of property, plant and equipment, right-of-use assets, and software related to exit activities; facility exit and closure costs, including the costs of physical y transferring inventory and fixed assets to other facilities; costs of integrating the IT systems of an acquired business to Gildan’s existing IT systems; legal, accounting and other professional fees (excluding costs of issuing debt or equity) directly incurred in connection with a business acquisition; purchase gains on business acquisitions; losses on business acquisitions achieved in stages; contingent amounts payable to sel ing shareholders under their employment agreements pursuant to a business acquisition; and the remeasurement of liabilities related to contingent consideration incurred in connection with a business acquisition.
(w) Cotton and cotton-based yarn procurements:
The Company contracts to buy cotton and cotton-based yarn with future delivery dates at fixed prices in order to reduce the effects of fluctuations in the prices of cotton used in the manufacture of its products. These contracts are not used for trading purposes and are not considered to be financial instruments as they are entered into for purchase and receipt in accordance with the Company’s expected usage requirements, and therefore are not measured at fair value. The Company commits to fixed prices on a percentage of its cotton and cotton-based yarn requirements up to eighteen months in the future. If the cost of committed prices for cotton and cotton-based yarn plus estimated costs to complete production exceed current sel ing prices, a loss is recognized for the excess as a charge to cost of sales.
(x) Government assistance:
Government assistance is recognized only when there is reasonable assurance the Company wil comply with al related conditions for receipt of the assistance. Government assistance, including grants and tax credits, related to operating expenses is accounted for as a reduction to the related expenses. Government assistance, including monetary and non-monetary grants and tax credits related to the acquisition of property, plant and equipment, is accounted for as a reduction of the cost of the related property, plant and equipment, and is recognized in net earnings using the same methods, periods and rates as for the related property, plant and equipment.
(y) Financial expenses (income):
Financial expenses (income) include: interest expense on borrowings, including realized gains and/or losses on interest rate swaps designated for hedge accounting; bank and other financial charges; amortization of debt facility fees, discount on the sales of trade accounts receivable; interest income on funds invested; interest on lease obligations; accretion of interest on discounted provisions; net foreign currency losses and/or gains; and losses and/or gains on financial derivatives that do not meet the criteria for effective hedge accounting.
(z) Income taxes:
Income tax expense is comprised of current and deferred income taxes, and is included in net earnings except to the extent that it relates to a business acquisition, or items recognized directly in equity or in other comprehensive income. Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to tax payable in respect of previous years.
Deferred income tax assets and liabilities are measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date, for al temporary differences caused when the tax bases of assets and liabilities differ from those reported in the financial statements. The Company recognizes deferred income tax assets for unused tax losses and deductible temporary differences only to the extent that, in management’s opinion, it is probable that future taxable profit wil be available against which the temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and are derecognized to the extent that it is no longer probable that the related tax benefit wil be realized.
		GILDAN 2022 REPORT TO SHAREHOLDERS 78

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(z) Income taxes (continued):
Deferred income tax is not recognized for the fol owing temporary differences: the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss at the time of the transaction; and, where the timing of the reversal of a temporary difference is control ed by the Company and it is probable that the temporary difference wil not reverse in the foreseeable future. In addition, deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwil .
In determining the amount of current and deferred income taxes, the Company takes into account the impact of uncertain tax positions and whether additional taxes and interest may be due. Provisions for uncertain tax positions are measured at the best estimate of the amounts expected to be paid upon ultimate resolution. The Company periodical y reviews and adjusts its estimates and assumptions of income tax assets and liabilities as circumstances warrant, such as changes to tax laws, administrative guidance, change in management’s assessment of the technical merits of its positions due to new information, and the resolution of uncertainties through either the conclusion of tax audits or expiration of prescribed time limits within relevant statutes.
(aa) Earnings per share:
Basic earnings per share are computed by dividing net earnings by the weighted average number of common shares outstanding for the year. Diluted earnings per share are computed using the weighted average number of common shares outstanding for the period adjusted to include the dilutive impact of stock options and restricted share units. The number of additional shares is calculated by assuming that al common shares held in trust for the purpose of settling non-Treasury restricted share units have been delivered, al dilutive outstanding options are exercised and al dilutive outstanding Treasury restricted share units have vested, and that the proceeds from such exercises, as wel as the amount of unrecognized share-based compensation which is considered to be assumed proceeds, are used to repurchase common shares at the average share price for the period. For Treasury restricted share units, only the unrecognized share-based compensation is considered assumed proceeds since there is no exercise price paid by the holder.
(bb) Share-based payments:
Stock options, Stock appreciation rights, Treasury and non-Treasury restricted share unitsStock options, Stock appreciation rights ("SARs"), Treasury restricted share units, and non-Treasury restricted share units are equity settled share-based payments, which are measured at fair value at the grant date. For stock options and SARs, the compensation cost is measured using the Black-Scholes option pricing model and is expensed over the award's vesting period. For Treasury and non-Treasury restricted share units, compensation cost is measured at the fair value of the underlying common share at the grant date and is expensed over the award's vesting period. Compensation expense is recognized in net earnings with a corresponding increase in contributed surplus. Any consideration paid by plan participants on the exercise of stock options is credited to share capital. Upon the exercise of stock options, the vesting of Treasury restricted share units, and upon delivery of the common shares for settlement of vesting non-Treasury restricted share units or SARs, the corresponding amounts previously credited to contributed surplus are transferred to share capital. The number of non-Treasury restricted share units remitted to the participants upon settlement is equal to the number of non-Treasury restricted share units awarded less units withheld to satisfy the participants' statutory withholding tax requirements. Stock options and Treasury restricted share units that are dilutive and meet non-market performance conditions as at the reporting date are considered in the calculation of diluted earnings per share, as per note 3(aa) to these consolidated financial statements.
Estimates for forfeitures and performance conditionsThe measurement of compensation expense for stock options, SARs, Treasury restricted share units and non-Treasury restricted share units is net of estimated forfeitures. For the portion of Treasury restricted share units and non-Treasury restricted share units that are issuable based on non-market performance conditions, the amount recognized as an expense is adjusted to reflect the number of awards for which the related service and performance conditions are expected to be met, such that the amount ultimately recognized as an expense is based on the number of awards that do meet the related service and non-market performance conditions at the vesting date.
		GILDAN 2022 REPORT TO SHAREHOLDERS 79

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(bb) Share-based payments (continued):
Deferred share unit planThe Company has a deferred share unit plan for independent members of the Company’s Board of Directors, who receive a portion of their compensation in the form of deferred share units (“DSUs”). These DSUs are cash settled awards and are initial y recognized in net earnings based on fair value at the grant date. The DSU obligation is included in accounts payable and accrued liabilities and is remeasured at fair value, based on the market price of the Company’s common shares, at each reporting date.
Employee share purchase plansFor employee share purchase plans, the Company's contribution, on the employee's behalf, is recognized as compensation expense with an offset to share capital, and consideration paid by employees on purchase of common shares is also recorded as an increase to share capital.
(cc) Leases:
At inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.
The Company recognizes a right-of-use ("ROU") asset and a lease liability at the lease commencement date. The ROU asset is initial y measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The ROU asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the ROU asset or the lease term. The lease term includes consideration of an option to renew or to terminate if the Company is reasonably certain to exercise that option. Lease terms range from 1 to 17 years for manufacturing, sales, distribution, and administrative facilities. In addition, the ROU asset is periodical y reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability.
The lease liability is initial y measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate. General y, the Company uses its incremental borrowing rate as the discount rate. Lease payments mainly include fixed, or in substance fixed, payments and variable lease payments that depend on an index or a rate. Variable lease payments that do not depend on an index or rate are not included in the measurement of the lease liability. The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, or if the Company changes its assessment of whether it wil exercise a purchase, extension, or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the ROU asset, or is recorded in profit or loss if the carrying amount of the ROU asset has been reduced to zero.
The Company has elected to apply the practical expedient not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less and leases of low-value assets. The lease payments associated with these leases are recognized as an expense on a straight-line basis over the lease term.
		GILDAN 2022 REPORT TO SHAREHOLDERS 80

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(dd) Use of estimates and judgments:
The preparation of financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.
Critical judgments in applying accounting policies:
The fol owing are critical judgments that management has made in the process of applying accounting policies and that have the most significant effect on the amounts recognized in the consolidated financial statements:
Determination of cash generating unitsThe identification of CGUs and grouping of assets into the respective CGUs is based on currently available information about actual utilization experience and expected future business plans. Management has taken into consideration various factors in identifying its CGUs. The Company has identified its CGUs for purposes of testing the recoverability and impairment of non-financial assets to be Textile & Sewing and Hosiery as they represent the lowest level at which the goodwil and indefinite life intangible assets are monitored for internal management purposes.
Income taxesThe Company’s income tax provisions and income tax assets and liabilities are based on interpretations of applicable tax laws, including income tax treaties between various countries in which the Company operates, as wel as underlying rules and regulations with respect to transfer pricing. These interpretations involve judgments and estimates and may be chal enged through government taxation audits that the Company is regularly subject to. New information may become available that causes the Company to change its judgment regarding the adequacy of existing income tax assets and liabilities; such changes wil impact net earnings in the period that such a determination is made.
Key sources of estimation uncertainty:
Key sources of estimation uncertainty that have a significant risk of resulting in a material adjustment to the carrying amount of assets and liabilities within the next financial year are as fol ows:
Inventory valuation The cost of inventories may no longer be recoverable if inventories are discontinued, damaged, in excess quantities, or if their sel ing prices or estimated forecast of product demand decline. Discontinued, damaged, and excess inventories are carried at the net realizable value, as those inventories are sold below cost in liquidation channels. In determining the net realizable value of finished goods, the Company considers recent recovery rates and current market conditions in these channels. The Company regularly reviews inventory quantities on hand, current production plans, and forecasted future sales, and inventories are written down to net realizable value when it is determined that they are no longer ful y recoverable. There is estimation uncertainty in relation to the identification of excess inventories and in the expected sel ing prices used in establishing the net realizable value. As at January 1, 2023, a 10% decrease or increase in the expected sel ing prices used to establish the net realizable value of discontinued, damaged, and excess inventories would result in either a decrease or an increase in inventories of approximately $1.6 mil ion, with a corresponding adjustment to cost of sales. If actual market conditions are less favorable than previously projected or if liquidation of the inventory which is no longer deemed ful y recoverable is more difficult than anticipated, additional write-downs may be required.
		GILDAN 2022 REPORT TO SHAREHOLDERS 81

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
3. SIGNIFICANT ACCOUNTING POLICIES (continued):
(dd) Use of estimates and judgments (continued):
Recoverability and impairment of non-financial assetsThe calculation of fair value less costs of disposal or value in use for purposes of measuring the recoverable amount of non-financial assets involves the use of significant assumptions and estimates with respect to a variety of factors, including estimated sales volumes, sel ing prices, input costs, SG&A expenses, cash flows, capital expenditures, and the selection of an appropriate earnings multiple or discount rate, al of which are subject to inherent uncertainties and subjectivity. The assumptions are based on annual business plans and other forecasted results, earnings multiples obtained by using market comparables as references, and discount rates which are used to reflect market-based estimates of the risks associated with the projected cash flows, based on the best information available as of the date of the impairment test. Changes in circumstances, such as technological advances, adverse changes in third-party licensing arrangements, changes to the Company’s business strategy, and changes in economic and market conditions can result in actual useful lives and future cash flows that differ significantly from estimates and could result in increased charges for amortization or impairment. Revisions to the estimated useful lives of finite-life non-financial assets or future cash flows constitute a change in accounting estimate and are applied prospectively. There can be no assurance that the estimates and assumptions used in the impairment tests wil prove to be accurate predictions of the future. If the future adversely differs from management’s best estimate of key economic assumptions and the associated cash flows material y decrease, the Company may be required to record material impairment charges or accelerated depreciation and amortization charges related to its non-financial assets. Please refer to note 11 for additional details on the recoverability of the Company’s cash-generating units.
		GILDAN 2022 REPORT TO SHAREHOLDERS 82

		NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
4. NEW ACCOUNTING STANDARDS AND INTERPRETATIONS NOT YET APPLIED:
Amendments to IAS 1, Presentation of Financial StatementsOn January 23, 2020, the IASB issued narrow-scope amendments to IAS 1, Presentation of Financial Statements, to clarify how to classify debt and other liabilities as current or non-current. The amendments (which affect only the presentation of liabilities in the statement of financial position) clarify that the classification of liabilities as current or non-current should be based on rights that are in existence at the end of the reporting period to defer settlement by at least twelve months and make explicit that only rights in place at the end of the reporting period should affect the classification of a liability; clarify that classification is unaffected by expectations about whether an entity wil exercise its right to defer settlement of a liability; and make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets, or services. On October 31, 2022, the IASB issued Non-current Liabilities with Covenants (Amendments to IAS 1). These further amendments clarify how to address the effects on classification and disclosure of covenants which an entity is required to comply with on or before the reporting date and covenants which an entity must comply with only after the reporting date.
These amendments wil be effective for annual periods beginning on or after January 1, 2024, with earlier application permitted and are to be applied retrospectively. The Company is currently evaluating the impact of these amendments on its consolidated financial statements.
Amendments to IAS 1 and IFRS Practice Statement 2, Disclosure of Accounting Policy InformationIn February 2021, the IASB issued amendments to IAS 1 Presentation of Financial Statements and IFRS Practice Statement 2 Making Materiality Judgements. The amendments help entities provide accounting policy disclosures that are more useful to primary users of financial statements by:
–	Replacing the requirement to disclose “significant” accounting policies under IAS 1 with a requirement to disclose “material” accounting policies. Under this, an accounting policy would be material if, when considered together with other information included in an entity’s financial statements, it can reasonably be expected to influence decisions that primary users of general purpose financial statements make on the basis of those financial statements.
–	Providing guidance in IFRS Practice Statement 2 to explain and demonstrate the application of the four-step materiality process to accounting policy disclosures.
The amendments shal be applied prospectively. The amendments to IAS 1 are effective for annual periods beginning on or after January 1, 2023. Earlier application is permitted. Once an entity applies the amendments to IAS 1, it is also permitted to apply the amendments to IFRS Practice Statement 2. The Company is currently evaluating the impact of the amendment on its consolidated financial statements.
Amendments to IAS 8, Definition of Accounting EstimatesIn February 2021, the IASB amended IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors to introduce a new definition of “accounting estimates” to replace the definition of “change in accounting estimates” and also include clarifications intended to help entities distinguish changes in accounting policies from changes in accounting estimates. This distinction is important because changes in accounting policies must be applied retrospectively while changes in accounting estimates are accounted for prospectively. The amendments are effective for annual periods beginning on or after January 1, 2023. Earlier application is permitted. The Company is currently evaluating the impact of the amendment on its consolidated financial statements.
Amendments to IAS 12, Deferred Tax related to Assets and Liabilities arising from a Single TransactionOn May 7, 2021, the IASB amended IAS 12 Income Taxes, to narrow the scope of the initial recognition exemption so that it does not apply to transactions that give rise to equal and offsetting temporary differences. The amendments are effective for annual periods beginning on or after January 1, 2023. The Company is currently evaluating the impact of the amendment on its consolidated financial statements.
			GILDAN 2022 REPORT TO SHAREHOLDERS 83

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. BUSINESS ACQUISITIONS/DISPOSITIONS:
Frontier Yarns - Plant 3On August 1, 2022 the Company sold a yarn spinning facility located in the U.S., which was the smal est of the four facilities that the Company acquired on December 10, 2021 as part of the Frontier Yarns acquisition. The sale included the disposition of inventory, equipment, goodwil and the transfer of a leasehold interest and related lease liability. The proceeds of disposition of $29.4 mil ion, of which $1.5 mil ion is being held in escrow subject to certain post-closing matters, exceeded the carrying value of net assets sold of $23.4 mil ion (including $13.9 mil ion of al ocated goodwil ), resulting in a pre-tax gain on disposal of $6.0 mil ion ($1.0 mil ion after tax). The pre-tax gain of $6.0 mil ion is included as a recovery in restructuring and acquisition-related costs.
OtherDuring the fourth quarter of fiscal 2022, the Company sold its sheer inventory and trademarks for total proceeds of $6.4 mil ion, of which $0.7 mil ion is being held in escrow subject to certain post-closing matters. The gain on disposal of these assets was insignificant.
Frontier YarnsOn December 10, 2021, the Company acquired 100% of the equity interest of Phoenix Sanford, LLC, the parent company of Frontier Yarns, for cash consideration (net of cash acquired and net of the settlement of pre-existing relationships) of $164.0 mil ion. Frontier Yarns operations included four facilities located in North Carolina. During 2021, approximately 40% of Frontier Yarns' production was dedicated to yarn sold to Gildan for textile manufacturing in Central America and the Caribbean. The acquisition wil al ow the Company to build on its global vertical y integrated supply chain through further internalizing yarn production and is expected to support incremental yarn needs for Gildan’s textile capacity expansion plans in Central America and the Caribbean.
The Company accounted for the acquisition using the acquisition method in accordance with IFRS 3, Business Combinations. The Company determined the fair value of the assets acquired and liabilities assumed based on management's best estimate of their fair values and taking into account al relevant information available at that time. Goodwil is attributable primarily to the assembled workforce and business processes of Frontier Yarns which were not recorded separately since they did not meet the recognition criteria for identifiable intangible assets. The final purchase price al ocation is summarized as fol ows:
Assets acquired:
	Inventories	$	23,799
	Prepaid expenses, deposits and other current assets(1)		29,845
	Property, plant and equipment		64,306
	Right-of-use assets		43,539
	Other non-current assets			9
			161,498
Liabilities assumed:
	Accounts payable and accrued liabilities		(30,191)
	Current portion of lease obligations		(1,940)
	Lease obligations		(41,599)
	Deferred income taxes(2)		(2,733)
			(76,463)
Goodwil (2)			78,933
Net assets acquired at fair value		$	163,968
Cash consideration paid at closing, net of cash acquired			167,040
Settlement of pre-existing relationships			(3,072)
		$	163,968
(1) Includes $26.2 mil ion of trade receivables of Frontier Yarns, that was classified in Prepaid expenses, deposits and other current assets in the consolidated statement of financial position of the Company. (2) During the fourth quarter of fiscal 2022, the Company recorded a purchase price al ocation adjustment due to a change in the preliminary valuation of assets acquired and liabilities assumed as of the acquisition date. As a result, the Company increased "Goodwil " and increased "Deferred income taxes" both by $1.8 mil ion.
						GILDAN 2022 REPORT TO SHAREHOLDERS 84

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. BUSINESS ACQUISITIONS/DISPOSITIONS (continued):
The consolidated results of the Company for fiscal 2021 included net earnings of $0.3 mil ion relating to the Frontier Yarns results of operations since the date of acquisition. Had the acquired business been consolidated from January 4, 2021, the consolidated income statement would have shown unchanged net sales and net earnings for the fiscal year ended January 2, 2022 of $612.4 mil ion. The pro forma amount has been adjusted to reflect the elimination of intercompany sales as if the acquisition occurred on January 4, 2021.
6. CASH AND CASH EQUIVALENTS:
Cash and cash equivalents consisted entirely of bank balances as at January 1, 2023 and January 2, 2022.
7. TRADE ACCOUNTS RECEIVABLE:
	January 1,		January 2,
		2023		2022
Trade accounts receivable	$ 264,179 $ 343,671
Al owance for expected credit losses		(15,394)		(13,704)
	$ 248,785 $ 329,967
As at January 1, 2023, trade accounts receivables being serviced under a receivables purchase agreement amounted to $228.9 mil ion (January 2, 2022 - $144.9 mil ion). The difference between the carrying amount of the receivables sold under the agreement and the cash received at the time of transfer was $5.1 mil ion for fiscal 2022 (2021 - $1.6 mil ion) and was recorded in bank and other financial charges. Refer to note 26 for additional information related to the receivables purchase agreement.
The movement in the al owance for expected credit losses in respect of trade receivables was as fol ows:
		2022		2021
Balance, beginning of fiscal year	$	(13,704) $		(18,994)
(Impairment) Reversal of impairment of trade accounts receivable		(2,150)			2,617
Write-off of trade accounts receivable		460		2,673
Balance, end of fiscal year	$	(15,394) $		(13,704)
The impairment of trade accounts receivable for fiscal 2022, is mainly related to specific provisions on higher risk customers, partial y offset by lower provisions on lower risk customers due to the decrease in trade accounts receivable. The reversal of impairment of trade accounts receivable for fiscal 2021 was mainly related to a decrease in expected credit loss rates to reflect the improved economic environment.
8. INVENTORIES:
	January 1,		January 2,
		2023		2022
Raw materials and spare parts inventories	$ 251,700 $ 183,065
Work in progress		77,726		53,482
Finished goods		896,514		537,811
	$ 1,225,940 $ 774,358
The amount of inventories recognized as an expense and included in cost of sales was $2,164.0 mil ion for fiscal 2022 (2021 - $1,910.6 mil ion). For fiscal 2022, cost of sales included an expense of $19.7 mil ion related the write-down of inventory to net realizable value. For fiscal 2021, cost of sales included a net recovery of $1.3 mil ion related to discontinued and closeout inventories carried at net realizable value.
						GILDAN 2022 REPORT TO SHAREHOLDERS 85

								NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
9. PROPERTY, PLANT AND EQUIPMENT:
					Assets not
		Buildings and	Manufacturing	Other	yet utilized in
	Land	improvements	equipment	equipment	operations	Total	2022
CostBalance, January 2, 2022
							$ 127,068	$	582,643	$ 1,109,128		$ 171,147	$	76,660				$ 2,066,646
Additions								4,321						22,578									48,665		8,375	158,595			242,534
Transfers								—						(8,128)	67,782		2,847		(62,501)	—
Disposals(1)								(449)						(5,791)	(19,974)	(7,003)					—		(33,217)
Balance, January 1, 2023							$ 130,940	$	591,302	$ 1,205,601		$ 175,366	$ 172,754				$ 2,275,963
Accumulated depreciationBalance, January 2, 2022
							$	—	$	244,971	$					699,988	$ 136,614	$				—	$ 1,081,573
Depreciation (note 21)								—						23,872									67,185		11,257			—	102,314
Disposals(1)								—						(5,460)	(10,856)	(6,777)					—		(23,093)
Balance, January 1, 2023							$	—	$	263,383	$					756,317	$ 141,094	$				—	$ 1,160,794
Carrying amount, January 1, 2023							$ 130,940	$	327,919	$					449,284	$	34,272	$ 172,754				$ 1,115,169
(1) Includes disposals of manufacturing equipment with a cost of $7.8 mil ion and accumulated depreciation of $2.0 mil ion related to the sale of Frontier Yarns - Plant 3. See note 5 for additional information. Disposals also include the write-off of certain equipment relating to the closure of the Company's Cedartown yarn facility in Georgia.
					Assets not
		Buildings and	Manufacturing	Other	yet utilized in
	Land	improvements	equipment	equipment	operations	Total	2021
CostBalance, January 3, 2021
							$ 123,549	$	571,464	$ 1,070,612		$ 174,760	$	16,156				$ 1,956,541
Additions								3,519						4,008									44,381		5,914	73,679			131,501
Additions through business acquisitions								—						13,397									50,817		92			—	64,306
Transfers								—						4,579									8,320		276	(13,175)	—
Disposals(1)								—		(10,805)						(65,002)	(9,895)					—		(85,702)
Balance, January 2, 2022							$ 127,068	$	582,643	$ 1,109,128		$ 171,147	$	76,660				$ 2,066,646
Accumulated depreciationBalance, January 3, 2021
							$	—	$	230,088	$					695,979	$ 133,674	$				—	$ 1,059,741
Depreciation (note 21)								—						22,696									58,435		11,045			—	92,176
Disposals(1)								—						(7,813)	(54,426)	(8,139)					—		(70,378)
Write-downs and impairments								—		—			—		34					—		34
Balance, January 2, 2022							$	—	$	244,971	$					699,988	$ 136,614	$				—	$ 1,081,573
Carrying amount, January 2, 2022							$ 127,068	$	337,672	$					409,140	$	34,533	$	76,660				$	985,073
(1) Included in disposals for fiscal 2021 are manufacturing equipment with a cost of $31.5 mil ion and accumulated depreciation of $25.2 mil ion that were determined to be unrepairable due to damages resulting from the two hurricanes which impacted the Company’s operations in Central America in November 2020. See note 17 (c) for additional information.
Effective January 3, 2022, the Company revised the estimated useful lives of certain textile manufacturing equipment based on a re-assessment of their expected use to the Company and recent experience of their economic lives. These assets, which were previously being depreciated on a straight-line basis over 10 years, are now depreciated on a straight-line basis over 15 years. For the year ended January 1, 2023, the change in estimate was made on a prospective basis and resulted in a reduction of depreciation of approximately $5.0 mil ion.
Assets not yet utilized in operations include expenditures incurred to date for plant expansions which are stil in process and equipment not yet placed into service as at the end of the reporting period.
As at January 1, 2023, there were contractual purchase obligations outstanding of approximately $168.5 mil ion for the purchase of property, plant and equipment compared to $159.4 mil ion as of January 2, 2022.
				GILDAN 2022 REPORT TO SHAREHOLDERS 86

						NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
10. RIGHT-OF-USE ASSETS AND LEASE OBLIGATIONS:
(a) Right-of-use assets:
The fol owing table presents the right-of-use assets for the Company:
	2022	2021
Balance, beginning of fiscal year			$	92,447 $	59,445
				Additions		11,688	8,132
				Business (dispositions) acquisitions		(8,426)	43,539
				Write-downs, impairments, and accelerated depreciation		(2,974)	(4,696)
				Depreciation (note 21)		(14,777)	(13,973)
Balance, end of fiscal year			$	77,958 $	92,447
(b) Lease obligations:
The Company’s leases are primarily for manufacturing, sales, distribution, and administrative facilities.
The fol owing table presents lease obligations recorded in the statement of financial position:
			January 1,	January 2,
	2023	2022
Current			$	13,828 $	15,290
Non-current				80,162	93,812
			$	93,990 $	109,102
Leases of certain facilities contain extension or termination options exercisable by the Company before the end of the non-cancel able contract period. The Company has applied judgment to determine the lease term for the contracts with renewal and termination options and has included renewal and termination options in the measurement of lease obligations when it is reasonably certain to exercise the options. The Company reassesses whether it is reasonably certain to exercise the options if there is a significant event or a significant change in circumstances within its control which impacts the original assessments made. As at January 1, 2023, potential undiscounted future lease payments related to renewal options not included in the measurement of lease obligations are $58.8 mil ion (January 2, 2022 - $45.8 mil ion).
The fol owing table presents the undiscounted future minimum lease payments under non-cancel able leases (including short term leases) as at January 1, 2023:
					January 1,
		2023
Less than one year	$	19,296
One to five years		51,941
More than five years		43,565
	$	114,802
For the year ended January 1, 2023, expenses relating to short-term leases and leases of low-value assets were $3.8 mil ion (2021 - $3.3 mil ion).
For the year ended January 1, 2023, the total cash outflow for recognized lease obligations (including interest) was $19.7 mil ion (2021 - $24.1 mil ion), of which $16.6 mil ion (2021 - $21.5 mil ion) was included as part of cash outflows from financing activities.
							GILDAN 2022 REPORT TO SHAREHOLDERS 87

				NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
11. INTANGIBLE ASSETS AND GOODWILL:
Intangible assets:
	Customer
	contracts and
	customer		License	Computer	Non-compete
2022	relationships	Trademarks	agreements	software	agreements	Total
CostBalance, January 2, 2022
	$	224,489	$ 226,172	$	72,796	$	67,157	$		1,790	$	592,404
Additions		—								—		—		5,205		—		5,205
Disposals		—								—		(2,346)	(1,788)		—		(4,134)
Balance, January 1, 2023	$	224,489	$ 226,172	$	70,450	$	70,574	$		1,790	$	593,475
Accumulated amortizationBalance, January 2, 2022
	$	148,132	$	19,127	$	66,929	$	49,796	$		1,790	$	285,774
Amortization (note 21)		11,194								—		2,561		5,397		—		19,152
Disposals		—								—		(1,967)	(1,725)		—		(3,692)
Write-downs and impairments		25,095		36,320		875		—			—		62,290
Balance, January 1, 2023	$	184,421	$	55,447	$	68,398	$	53,468	$		1,790	$	363,524
Carrying amount, January 1, 2023	$	40,068	$ 170,725	$	2,052	$	17,106	$		—	$	229,951
	Customer
	contracts and
	customer		License	Computer	Non-compete
2021	relationships	Trademarks	agreements	software	agreements	Total
CostBalance, January 3, 2021
	$	224,489	$ 226,172	$	72,796	$	64,295	$		1,790	$	589,542
Additions										—							—		—	3,635	—	3,635
Disposals										—							—		—	(773)	—	(773)
Balance, January 2, 2022	$	224,489	$ 226,172	$	72,796	$	67,157	$		1,790	$	592,404
Accumulated amortizationBalance, January 3, 2021
	$	142,131	$	46,351	$	64,347	$	45,022	$		1,790	$	299,641
Amortization (note 21)		9,944								292		2,582		5,258		—		18,076
Disposals										—							—		—	(484)	—	(484)
(Impairment reversal, net of write-downs)		(3,943)	(27,516)	—		—			—		(31,459)
Balance, January 2, 2022	$	148,132	$	19,127	$	66,929	$	49,796	$		1,790	$	285,774
Carrying amount, January 2, 2022	$	76,357	$ 207,045	$	5,867	$	17,361	$		—	$	306,630
During fiscal 2022, the Company recorded an impairment charge of $62.3 mil ion relating to intangible assets (both definite and indefinite life) acquired in previous business acquisitions.
During fiscal 2021, the Company recorded an impairment reversal, net of write-downs, of $31.5 mil ion. The impairment reversal, net of write-downs includes a $55.6 mil ion impairment reversal relating to intangible assets (both definite and indefinite life) acquired in previous business acquisitions, partial y offset by a $24.1 mil ion write-off of certain intangible assets relating to the Company's Hosiery CGU. The write-off of intangible assets included a write-down of $10.4 mil ion in trademarks and $13.7 mil ion in customer relationships, that were assessed as having no future economic benefit. These asset write-offs related to the Company’s plan to exit its sheer panty hose, tights, leggings, ladies shapewear, intimates, and accessories products.
The carrying amount of internal y-generated assets within computer software was $13.6 mil ion as at January 1, 2023
(January 2, 2022 - $14.1 mil ion). Included in computer software as at January 1, 2023 is $4.4 mil ion (January 2, 2022 - $3.6 mil ion) of assets not yet utilized in operations.
				GILDAN 2022 REPORT TO SHAREHOLDERS 88

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
11. INTANGIBLE ASSETS AND GOODWILL (continued):
Goodwill:
	2022	2021
Balance, beginning of fiscal year			$ 283,815	$ 206,636
Goodwil (disposed) acquired				(13,892)	77,179
Purchase price al ocation adjustment				1,754				—
Balance, end of fiscal year			$ 271,677	$ 283,815
Recoverability of cash-generating units:
Goodwil acquired through business acquisitions and intangibles have been al ocated to the Company's CGUs as fol ows:
			January 1,	January 2,
	2023	2022
Textile & Sewing:
Goodwil			$ 271,677	$ 283,815
Definite life intangible assets (excluding computer software)				19,282				23,430
Indefinite life intangible assets				93,400				93,400
			$ 384,359	$ 400,645
Hosiery:
Goodwil			$	—			$	—
Definite life intangible assets (excluding computer software)				22,838				58,794
Indefinite life intangible assets				77,325				113,645
			$ 100,163	$ 172,439
In assessing whether goodwil and indefinite life intangible assets are impaired, the carrying amounts of the CGUs (including goodwil and indefinite life intangible assets) are compared to their recoverable amounts. The recoverable amounts of CGUs are based on the higher of the value in use and fair value less costs of disposal.
The Company performed its annual impairment review for goodwil and indefinite life intangible assets as at January 1, 2023 and January 2, 2022. The estimated recoverable amount for the Textile & Sewing CGU exceeded its carrying amounts and as a result, there was no impairment identified. The carrying value for the Hosiery CGU was in excess of its estimated recoverable amount and as a result the Company recorded an impairment charge of $62.3 mil ion for the year ended January 1, 2023 relating to intangible assets (both definite and indefinite life) acquired in previous business acquisitions. For the year ended January 2, 2022, the estimated recoverable amount for the Hosiery CGU was in excess of its carrying value resulting in an impairment reversal of $55.6 mil ion, relating to intangible assets (both definite and indefinite life) acquired in previous business acquisitions.
Recoverable amount for Textile & Sewing and Hosiery CGUsThe Company determined the recoverable amounts of the Textile & Sewing and Hosiery CGUs based on the fair value less costs of disposal method. The fair values of the Textile & Sewing and Hosiery CGUs were based on a multiple applied to adjusted EBITDA (as defined in note 25) for the next year, which takes into account financial forecasts approved by senior management. The key assumptions for the fair value less costs of disposal method include estimated sales volumes, sel ing prices, input costs, and SG&A expenses in determining forecasted adjusted EBITDA, as wel as the multiple applied to forecasted adjusted EBITDA. The adjusted EBITDA multiple was obtained by using market comparables as a reference. The values assigned to the key assumptions represent management’s assessment of future trends and have been based on historical data from external and internal sources.
						GILDAN 2022 REPORT TO SHAREHOLDERS 89

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
11. INTANGIBLE ASSETS AND GOODWILL (continued):
Recoverability of cash-generating units (continued):
Textile & Sewing CGUFor the Textile & Sewing CGU, no reasonably possible change in the key assumptions used in determining the recoverable amount would result in any impairment of goodwil or indefinite life intangible assets.
Hosiery CGU Based on the results of the impairment test performed on January 1, 2023, the recoverable amount of the CGU of $265.5 mil ion (2021 - $544.0 mil ion) is lower than the carrying value and as a result there was $62.3 mil ion impairment identified.
The fair value of the Hosiery CGU was based on a multiple applied to the risk-adjusted forecasted adjusted EBITDA (see definition of adjusted EBITDA in note 25). The key assumptions used in the estimation of the recoverable amount for the Hosiery CGU are the risk-adjusted forecasted adjusted EBITDA for the next year and the adjusted EBITDA multiple of 7.5 (January 1, 2023 test) and 10 (January 2, 2022 test). The adjusted EBITDA multiple was obtained by using market comparables as a reference. The most significant assumptions that form part of the risk-adjusted forecasted adjusted EBITDA for the Hosiery CGU relate to estimated sales volumes, sel ing prices, input costs, and SG&A expenses. A decrease in the risk adjusted forecasted adjusted EBITDA of 10% in the Hosiery CGU combined with a decrease in the adjusted EBITDA multiple by a factor of 1 would result in an additional impairment of approximately $50.0 mil ion. Conversely an increase in the risk adjusted forecasted adjusted EBITDA of 10% combined with an increase in the adjusted EBITDA multiple by a factor of 1 would result in a reduction of impairment of approximately $55.0 mil ion. The values assigned to the key assumptions represent management’s assessment of future trends and have been based on historical data from external and internal sources.
		GILDAN 2022 REPORT TO SHAREHOLDERS 90

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
12. LONG-TERM DEBT:
		Principal amount
	Effective
	interest		Maturity	January 1,	January 2,
	rate (1)		date	2023		2022
Non-current portion of long-term debtRevolving long-term bank credit facility, interest at variable U.S. interest
			March
	3.4%				$	330,000 $	—
rate(2)(3)			2027
			June
Term loan, interest at variable U.S. interest rate, payable monthly(2)(4)	3.0%					300,000		300,000
			2026
Notes payable, interest at fixed rate of 2.70%, payable semi-annual y(5)	n/a					—	100,000 August
			2023
Notes payable, interest at Adjusted LIBOR plus a spread of 1.53%,
	n/a					—	50,000 August
payable quarterly(5)(6)			2023
Notes payable, interest at fixed rate of 2.91%, payable semi-annual y(5)	2.9%					100,000		100,000 August
			2026
Notes payable, interest at Adjusted LIBOR plus a spread of 1.57%,
	2.9%					50,000		50,000 August
payable quarterly(5)(6)			2026
					$	780,000 $		600,000
Current portion of long-term debt
Notes payable, interest at fixed rate of 2.70%, payable semi-annual y(5)	2.7%					100,000	— August
			2023
Notes payable, interest at Adjusted LIBOR plus a spread of 1.53%,
	2.7%					50,000	— August
payable quarterly(5)(6)			2023
					$	150,000 $	—
Long-term debt					$	930,000 $		600,000
(1) Represents the annualized effective interest rate for the year ended January 1, 2023, including the cash impact of interest rate swaps, where applicable.(2) SOFR advances at adjusted Term SOFR (includes a 0% to 0.25% reference rate adjustment) plus a spread ranging from 1% to 3%. (3) The Company’s committed unsecured revolving long-term bank credit facility of $1 bil ion provides for an annual extension which is subject to the approval of the lenders. The spread added to the adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as defined in the credit facility agreement and its amendments). In addition, an amount of $43.9 mil ion (January 2, 2022 - $51.1 mil ion) has been committed against this facility to cover various letters of credit. (4) The unsecured term loan is non-revolving and can be prepaid in whole or in part at any time with no penalties. The spread added to the adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as defined in the term loan agreements and its amendments).(5) The unsecured notes issued for a total aggregate principal amount of $300 mil ion to accredited investors in the U.S. private placement market can be prepaid in whole or in part at any time, subject to the payment of a prepayment penalty as provided for in the Note Purchase Agreement.(6) Adjusted LIBOR rate is determined on the basis of floating rate notes that bear interest at a floating rate plus a spread of 1.53%.
On April 20, 2021, the Company ful y repaid its $400 mil ion unsecured two-year term loan which was due on April 6, 2022. In June 2021, the Company amended its unsecured term loan of $300 mil ion to extend the maturity date from April 2025 to June 2026.
On March 25, 2022, the Company amended and extended its unsecured revolving long-term bank credit facility of $1 bil ion to March 2027. As part of the amendment, LIBOR references were replaced with Term Secured Overnight Financing Rate (‘ Term SOFR’ ) and the revolving facility includes a sustainability-linked loan ("SLL") structure, whereby its applicable margins are adjusted upon achievement of certain sustainability targets, commencing in 2023.
On March 25, 2022, the Company amended its $300 mil ion term loan to replace LIBOR references by Term SOFR references.
		GILDAN 2022 REPORT TO SHAREHOLDERS 91

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
12. LONG-TERM DEBT (continued):
On June 30, 2022, the Company amended its notes purchase agreement to include LIBOR fal back provisions to replace LIBOR with adjusted term SOFR, adjusted daily simple SOFR or any relevant alternate rate selected by the note holders and the Company upon a benchmark transition event or early opt-in election.
The Company applied the IFRS 9 interest rate benchmark reform practical expedient for amendments required by the interest rate reform to the revolving-long term bank credit facility, term loan and related interest rate swap agreements. The Company and its counterparties under interest rate swap agreements are in the process of negotiating the substitution of reference rates in such agreements.
Under the terms of the revolving facility, term loan facility, and notes, the Company is required to comply with certain covenants, including maintenance of financial ratios. The Company was in compliance with al financial covenants at January 1, 2023.
13. OTHER NON-CURRENT LIABILITIES:
	January 1,		January 2,
		2023		2022
Employee benefit obligation - Statutory severance and pre-notice (a)	$	42,127 $		42,931
Employee benefit obligation - Defined contribution plan (b)		3,383	3,742
Provisions (c)		10,707		13,189
	$	56,217 $		59,862
(a) Statutory severance and pre-notice obligations:
		2022		2021
Obligation, beginning of fiscal year	$	42,931 $		19,889
Service cost		18,166		13,942
Interest cost		8,543	6,562
Actuarial (gain) loss(1)		(8,094)		21,678
Foreign exchange gain		(626)		(179)
Benefits paid		(18,793)		(18,961)
Obligation, end of fiscal year	$	42,127 $		42,931
(1) The actuarial gain in fiscal 2022 is mainly due to changes in the actuarial assumptions used to determine the statutory severance obligations. The actuarial loss in fiscal 2021 is due to changes in the actuarial assumptions used to determine the statutory severance obligations.
Significant assumptions for the calculation of the statutory severance obligations included the use of a discount rate ranging between 8.5% and 11.0% (2021 - between 8.5% and 9.2%) and rates of compensation increases between 8.0% and 10.5% (2021 - 7.75% and 10.5%). A 1% increase in the discount rates would result in a corresponding decrease in the statutory severance obligations of $8.0 mil ion, and a 1% decrease in the discount rates would result in a corresponding increase in the statutory severance obligations of $9.3 mil ion. A 1% increase in the rates of compensation increases used would result in a corresponding increase in the statutory severance obligations of $9.6 mil ion, and a 1% decrease in the rates of compensation increases used would result in a corresponding decrease in the statutory severance obligations of $8.3 mil ion.
The cumulative amount of actuarial losses recognized in other comprehensive income as at January 1, 2023 was $26.5 mil ion (January 2, 2022 - $34.6 mil ion) which have been reclassified to retained earnings in the period in which they were recognized.
(b) Defined contribution plan:
During fiscal 2022, defined contribution expenses were $4.7 mil ion (2021 - $5.3 mil ion).
						GILDAN 2022 REPORT TO SHAREHOLDERS 92

				NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
13. OTHER NON-CURRENT LIABILITIES (continued):
(c) Provisions:
The fol owing table presents the provisions for decommissioning and site restoration costs of the Company:
	2022	2021
Balance, beginning of fiscal year			$	13,189 $	12,240
Changes in estimates made during the fiscal year				(2,689)	796
Accretion of interest				207	153
Balance, end of fiscal year			$	10,707 $	13,189
Provisions as at January 1, 2023 include estimated future costs of decommissioning and site restoration for certain assets located at the Company’s textile and sock facilities for which the timing of settlement is uncertain, but has been estimated to be in excess of twenty years.
14. EQUITY:
(a) Shareholder rights plan:
The Company has a shareholder rights plan which provides the Board of Directors and the shareholders with additional time to assess any unsolicited take-over bid for the Company and, where appropriate, pursue other alternatives for maximizing shareholder value.
(b) Accumulated other comprehensive income ("AOCI"):
Accumulated other comprehensive income includes the changes in the fair value of the effective portion of qualifying cash flow hedging instruments, for which the hedged transaction has not yet occurred at the end of the fiscal year.
(c) Share capital:
Authorized:Common shares, authorized without limit as to number and without par value. First preferred shares, without limit as to number and without par value, issuable in series and non-voting. Second preferred shares, without limit as to number and without par value, issuable in series and non-voting. As at January 1, 2023 and January 2, 2022, none of the first and second preferred shares were issued.
Issued:As at January 1, 2023, there were 179,709,339 common shares (January 2, 2022 - 192,267,273) issued and outstanding, which are net of 8,129 common shares (January 2, 2022 - 8,759) that have been purchased and are held in trust as described in note 14(e).
			GILDAN 2022 REPORT TO SHAREHOLDERS 93

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
14. EQUITY (continued):
(d) Normal course issuer bid ("NCIB"):
On August 4, 2021, the Company received approval from the Toronto Stock Exchange (TSX) to renew its NCIB commencing on August 9, 2021 to purchase for cancel ation up to 9,926,177 common shares, representing approximately 5% of the Company’s issued and outstanding common shares. During the year ended January 2, 2022, the Company repurchased for cancel ation a total of 6,475,375 common shares under its NCIB programs for a total cost of $250.4 mil ion. Of the total cost of $250.4 mil ion, $6.2 mil ion was charged to share capital and $244.3 mil ion was charged to retained earnings.
On February 22, 2022, the Company received approval from the TSX to amend its current NCIB, which commenced on August 9, 2021, in order to increase the maximum number of common shares that may be repurchased from 9,926,177, or 5% of the Company’s issued and outstanding common shares as at July 31, 2021 (the reference date for the NCIB), to 19,477,744 common shares, representing 10% of the public float as at July 31, 2021. No other terms of the NCIB have been amended.
In August 2022, the Company received approval from the TSX to renew its normal course issuer bid (NCIB) program commencing on August 9, 2022, to purchase for cancel ation a maximum of 9,132,337 common shares, representing 5% of the Company's issued and outstanding common shares, as at July 31, 2022 (the reference date for the NCIB). Under the NCIB, the Company is authorized to make purchases under the normal course issuer bid during the period from August 9, 2022 to August 8, 2023 in accordance with the requirements of the TSX. Purchases can be made by means of open market transactions on both the TSX and the New York Stock Exchange (NYSE), or alternative Canadian trading systems, if eligible, or by such other means as may be permitted by securities regulatory authorities, including pre-arranged crosses, exempt offers, private agreements under an issuer bid exemption order issued by securities regulatory authorities and block purchases of common shares.
During the third quarter of fiscal 2022, the Company completed share repurchases under its NCIB ending August 8, 2022 and fol owing the renewal of the Company's NCIB, effective August 9, 2022, the Company continued to repurchase shares. During the year ended January 1, 2023, the Company repurchased for cancel ation a total of 13,096,866 common shares purchased for cancel ation, for a total cost of $443.9 mil ion, of which $13.3 mil ion was charged to share capital and $430.5 mil ion was charged to retained earnings.
(e) Common shares purchased as settlement for non-Treasury RSUs:
The Company has established a trust for the purpose of settling the vesting of non-Treasury RSUs. For non-Treasury RSUs that are to be settled in common shares in lieu of cash, the Company directs the trustee to purchase common shares of the Company on the open market to be held in trust for and on behalf of the holders of non-Treasury RSUs until they are delivered for settlement, when the non-Treasury RSUs vest. For accounting purposes, the common shares are considered as held in treasury, and recorded as a temporary reduction of outstanding common shares and share capital. Upon delivery of the common shares for settlement of the non-Treasury RSUs, the number of common shares outstanding is increased, and the amount in contributed surplus is transferred to share capital. As at January 1, 2023, a total of 8,129 common shares purchased as settlement for non-Treasury RSUs were considered as held in treasury and recorded as a temporary reduction of outstanding common shares and share capital (January 2, 2022 - 8,759 common shares).
(f) Contributed surplus:
The contributed surplus account is used to record the accumulated compensation expense related to equity-settled share-based compensation transactions. Upon the exercise of stock options, the vesting of Treasury RSUs, and the delivery of common shares for settlement of vesting non-Treasury RSUs or SARs, the corresponding amounts previously credited to contributed surplus are transferred to share capital, except for the portion of the share-based payment that the Company settles on a net basis when the Company has an obligation under tax laws to withhold an amount for an employee’s tax obligation, in which case the corresponding amounts previously credited to contributed surplus are transferred to accounts payable and accrued liabilities.
		GILDAN 2022 REPORT TO SHAREHOLDERS 94

						NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS:
(a) Financial instruments - carrying amounts and fair values:
The carrying amounts and fair values of financial assets and liabilities included in the consolidated statements of financial position are as fol ows:
	January 1,		January 2,
		2023		2022
Financial assetsAmortized cost: Cash and cash equivalents
	$ 150,417 $ 179,246
Trade accounts receivable		248,785		329,967
Financial assets included in prepaid expenses, deposits and other current assets		48,274		69,995
Long-term non-trade receivables included in other non-current assets		118		390
Derivative financial assets included in prepaid expenses, deposits and other current
					assets		23,765	62,758
Financial liabilitiesAmortized cost: Accounts payable and accrued liabilities (1)
	$ 462,496 $ 436,073
Long-term debt - bearing interest at variable rates		730,000		400,000
Long-term debt - bearing interest at fixed rates (2)		200,000		200,000
Derivative financial liabilities included in accounts payable and accrued liabilities		8,712	4,328
1) Accounts payable and accrued liabilities include $26.9 mil ion (January 2, 2022 - $18.1 mil ion) under supply-chain financing arrangements (reverse factoring) with a financial institution, whereby receivables due from the Company to certain suppliers can be col ected by the suppliers from a financial institution before their original due date. These balances are classified as accounts payable and accrued liabilities and the related payments as cash flows from operating activities, given the principal business purpose of the arrangement is to provide funding to the supplier and not the Company, the arrangement does not significantly extend the payment terms beyond the normal terms agreed with other suppliers, and no additional deferral or special guarantees to secure the payments are included in the arrangement. Accounts payable and accrued liabilities also include balances payable of $35.7 mil ion (January 2, 2022 - $48.8 mil ion) resulting mainly from a one-week timing difference between the col ection of sold receivables and the weekly remittance to our bank counterparty under our receivables purchase agreement that is disclosed in note 7 to these consolidated financial statements.2) The fair value of the long-term debt bearing interest at fixed rates was $197.1 mil ion as at January 1, 2023 (January 2, 2022 - $212.2 mil ion).
							GILDAN 2022 REPORT TO SHAREHOLDERS 95

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(a) Financial instruments - carrying amounts and fair values (continued):
Short-term financial assets and liabilities The Company has determined that the fair value of its short-term financial assets and liabilities approximates their respective carrying amounts as at the reporting dates due to the short-term maturities of these instruments, as they bear variable interest-rates or because the terms and conditions are comparable to current market terms and conditions for similar items.
Non-current assets and long-term debt bearing interest at variable ratesThe fair values of the long-term non-trade receivables included in other non-current assets and the Company’s long-term debt bearing interest at variable rates also approximate their respective carrying amounts because the interest rates applied to measure their carrying amounts approximate current market interest rates.
Long-term debt bearing interest at fixed ratesThe fair value of the long-term debt bearing interest at fixed rates is determined using the discounted future cash flows method and at discount rates based on yield to maturities for similar issuances. The fair value of the long-term debt bearing interest at fixed rates was measured using Level 2 inputs in the fair value hierarchy. In determining the fair value of the long-term debt bearing interest at fixed rates, the Company takes into account its own credit risk and the credit risk of the counterparties.
DerivativesDerivative financial instruments are designated as effective hedging instruments and consist of foreign exchange and commodity forward, option, and swap contracts, as wel as floating-to-fixed interest rate swaps to fix the variable interest rates on a designated portion of borrowings under the term loan and unsecured notes. The fair value of the forward contracts is measured using a general y accepted valuation technique which is the discounted value of the difference between the contract’s value at maturity based on the rate set out in the contract and the contract’s value at maturity based on the rate that the counterparty would use if it were to renegotiate the same contract terms at the measurement date under current conditions. The fair value of the option contracts is measured using option pricing models that utilize a variety of inputs that are a combination of quoted prices and market-corroborated inputs, including volatility estimates and option adjusted credit spreads. The fair value of the interest rate swaps is determined based on market data, by measuring the difference between the fixed contracted rate and the forward curve for the applicable floating interest rates.
The Company also has a total return swap (“TRS”) outstanding that is intended to reduce the variability of net earnings associated with deferred share units, which are settled in cash. The TRS is not designated as a hedging instrument and, therefore, the fair value adjustment at the end of each reporting period is recognized in sel ing, general and administrative expenses. The fair value of the TRS is measured by reference to the market price of the Company’s common shares, at each reporting date. The TRS has a one-year term, may be extended annual y, and the contract al ows for early termination at the option of the Company. As at January 1, 2023, the notional amount of TRS outstanding was 362,608 shares (January 2, 2022 - 319,639 shares) and the carrying amount and fair value included in accounts payable and accrued liabilities was $4.7 mil ion (January 2, 2022 - $0.03 mil ion included in prepaid expenses, deposits and other current assets).
Derivative financial instruments were measured using Level 2 inputs in the fair value hierarchy. In determining the fair value of derivative financial instruments the Company takes into account its own credit risk and the credit risk of the counterparties.
		GILDAN 2022 REPORT TO SHAREHOLDERS 96

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(b) Derivative financial instruments - hedge accounting:
During fiscal 2022 and 2021, the Company entered into foreign exchange and commodity forward, option, and swap contracts in order to minimize the exposure of forecasted cash inflows and outflows in currencies other than the U.S. dol ar and to manage its exposure to movements in commodity prices, as wel as floating-to-fixed interest rate swaps to fix the variable interest rates on a designated portion of borrowings under the term loan and unsecured notes.
The forward foreign exchange contracts were designated as cash flow hedges and qualified for hedge accounting. The forward foreign exchange contracts outstanding as at January 1, 2023 and January 2, 2022 consisted primarily of contracts to reduce the exposure to fluctuations in Canadian dol ars, Euros, Australian dol ars, Pounds sterling, and Mexican pesos against the U.S. dol ar.
The commodity forward, option, and swap contracts were designated as cash flow hedges and qualified for hedge accounting. The commodity contracts outstanding as at January 1, 2023 and January 2, 2022 consisted primarily of forward, col ar, and swap contracts to reduce the exposure to movements in commodity prices.
The floating-to-fixed interest rate swaps were designated as cash flow hedges and qualified for hedge accounting. The floating-to-fixed interest rate swaps contracts outstanding as at January 1, 2023 and January 2, 2022 served to fix the variable interest rates on the designated interest payments of a portion of the Company's long-term debt.
The fol owing table summarizes the Company’s commitments to buy and sel foreign currencies (cash flow hedges) as at January 1, 2023:
	Carrying and fair value	Maturity
			Notional foreign	Average	Notional	Prepaid expenses,	Accounts
			currency amount	exchange	U.S. $ deposits and other		payable and	0 to 12
			equivalent	rate	equivalent	current assets					accrued liabilities	months
Forward foreign exchange contracts:
									Sel GBP/Buy USD						39,600	1.2000	$ 47,520	$			686	$	(1,023)	$	(337)
									Sel EUR/Buy USD						42,544	1.0513		44,726				328		(1,355)		(1,027)
									Sel CAD/Buy USD						47,531	0.7534		35,812				707					(56)			651
									Buy CAD/Sel USD						30,497	0.7662		23,367				17		(815)		(798)
									Sel AUD/Buy USD						12,258	0.6836		8,379				153		(122)				31
									Sel MXN/Buy USD						63,776	0.0469		2,989		—	(242)		(242)
									Buy EUR/Sel USD						3,137	1.0592		3,323				56					(14)			42
					$ 166,116	$	1,947					$	(3,627)	$	(1,680)
The fol owing table summarizes the Company’s commitments to buy and sel foreign currencies (cash flow hedges) as at January 2, 2022:
	Carrying and fair value	Maturity
			Notional foreign	Average	Notional	Prepaid expenses,	Accounts
			currency amount	exchange	U.S. $	deposits and other	payable and	0 to 12
			equivalent	rate	equivalent	current assets					accrued liabilities	months
Forward foreign exchange contracts:
									Sel GBP/Buy USD						26,752	1.3769	$ 36,834	$			808	$				(54)	$		754
									Sel EUR/Buy USD						29,390	1.1916		35,020	1,592					—		1,592
									Sel CAD/Buy USD						39,274	0.8015		31,478				665					—			665
									Buy CAD/Sel USD						31,016	0.7840		24,316				92					(88)			4
									Sel AUD/Buy USD						8,885	0.7427		6,599				161					(13)			148
									Sel MXN/Buy USD						151,791	0.0480		7,279				39					(11)			28
					$ 141,526	$	3,357					$	(166)	$	3,191
										GILDAN 2022 REPORT TO SHAREHOLDERS 97

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

15. FINANCIAL INSTRUMENTS (continued):

(b) Derivative financial instruments - hedge accounting (continued):

The fol owing table summarizes the Company's commodity contracts outstanding (cash flow hedges) as at January 1, 2023:

Carrying and fair value

Maturity

Prepaid expenses,

Accounts

Type of

deposits and other

payable and

0 to 12

commodity

Notional amount (1)

current assets

accrued liabilities

months

Forward contracts

Cotton

118.9 mil ion pounds

5,105

—

5,105

Swap & option contracts

Energy

1.7 mil ion gal ons

253

(358)

(105)

5,358

(358)

5,000

(1) Notional amounts are not in thousands.

The fol owing table summarizes the Company's commodity contracts outstanding (cash flow hedges) as at January 2, 2022:

Carrying and fair value

Maturity

Prepaid expenses,

Accounts

Type of

deposits and other

payable and

0 to 12

commodity

Notional amount (1)

current assets

accrued liabilities

months

Forward contracts

Cotton

251.0 mil ion pounds

56,419

—

$ 56,419

Swap & option contracts

Energy

5.7 mil ion gal ons

1,660

(102)

1,558

58,079

(102)

$ 57,977

(1) Notional amounts are not in thousands.

GILDAN 2022 REPORT TO SHAREHOLDERS 98

							NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(b) Derivative financial instruments - hedge accounting (continued):
The fol owing table summarizes the Company’s floating-to-fixed interest rate swap contracts outstanding (cash flow hedges) as at January 1, 2023:
	Carrying and fair value
		Notional	Prepaid expenses,	Accounts
		amount of			Maturity	Fixed	Floating	deposits and other	payable and
		borrowings			date			Pay / Receive	rate	rate(2)	current assets				accrued liabilities
Term Loan(1)
					April 30,			Pay fixed rate /
		$	75,000			2023					receive floating rate	2.85 % US LIBOR	$			435	$		—
					April 30,			Pay fixed rate /
			50,000			2024					receive floating rate	1.51 % US LIBOR		2,124				—
					April 30,			Pay fixed rate /
			25,000			2025					receive floating rate	1.06 % US LIBOR		1,839				—
					April 30,			Pay fixed rate /
			50,000			2025					receive floating rate	0.78 % US LIBOR		3,346				—
					June 30,			Pay fixed rate /
			25,000			2026					receive floating rate	1.59 % US LIBOR				443			—
					June 30,			Pay fixed rate /
			25,000			2026					receive floating rate	1.23 % US LIBOR		1,999				—
Unsecured Notes
					August 25,			Pay fixed rate /
			50,000			2023					receive floating rate	1.18 % US LIBOR		1,394				—
					August 25,			Pay fixed rate /
			50,000			2026					receive floating rate	1.34 % US LIBOR		4,880				—
	$	16,460			$								—
(1) The notional amounts for the interest rate swap contracts maturing in 2025 and 2026 are extensions to the $100 mil ion interest rate swap contracts original y entered into related to the $300 mil ion term loan.
(2) The Company and its counterparties under interest rate swap agreements have begun discussions to negotiate the substitution of reference rates in such agreements.
			GILDAN 2022 REPORT TO SHAREHOLDERS 99

							NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(b) Derivative financial instruments - hedge accounting (continued):
The fol owing table summarizes the Company’s floating-to-fixed interest rate swap contracts outstanding (cash flow hedges) as at January 2, 2022:
	Carrying and fair value
		Notional	Prepaid expenses,	Accounts
		amount of			Maturity	Fixed	Floating	deposits and other	payable and
		borrowings			date			Pay / Receive	rate	rate	current assets								accrued liabilities
Term Loan(1)
					April 30,			Pay fixed rate /
		$	75,000			2023			receive floating rate	2.85 % US LIBOR	$									—	$	(2,272)
					April 30,			Pay fixed rate /
			50,000			2024			receive floating rate	1.51 % US LIBOR										32		(744)
					April 30,			Pay fixed rate /
			25,000			2025			receive floating rate	1.06 % US LIBOR										167		(154)
					April 30,			Pay fixed rate /
			50,000			2025						receive floating rate	0.78 % US LIBOR										624					—
					June 30,			Pay fixed rate /
			25,000			2026						receive floating rate	1.59 % US LIBOR										—					(22)
					June 30,			Pay fixed rate /
			25,000			2026						receive floating rate	1.23 % US LIBOR										171					—
Unsecured Notes
					August 25,			Pay fixed rate /
			50,000			2023						receive floating rate	1.18 % US LIBOR										—		(380)
					August 25,			Pay fixed rate /
			50,000			2026						receive floating rate	1.34 % US LIBOR										328		(454)
	$	1,322			$	(4,026)
(1) The notional amounts for the interest rate swap contracts maturing in 2025 and 2026 were extensions to the $100 mil ion interest rate swap contracts original y entered into related to the $300 mil ion term loan.
The fol owing table summarizes the Company’s hedged items as at January 1, 2023:
	Change in
						Carrying amount of	value used for			Cash flow
						the hedged item	calculating hedge						hedge reserve
						Assets	Liabilities	ineffectiveness			(AOCI)
Cash flow hedges:
Foreign currency risk:
													Forecast sales	$	— $	—	$	(1,359) $			1,359
													Forecast expenses		—	—								(750)	750
Commodity risk:
													Forecast purchases		—	—		(4,112)			4,112
Interest rate risk:
													Forecast interest payments		—	—		16,066									(16,066)
														$	— $	—	$	9,845								$	(9,845)
No ineffectiveness was recognized in net earnings as the change in value of the hedging instrument used for calculating ineffectiveness was the same or smal er as the change in value of the hedged items used for calculating the ineffectiveness.
			GILDAN 2022 REPORT TO SHAREHOLDERS 100

								NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(b) Derivative financial instruments - hedge accounting (continued):
The fol owing table summarizes the Company’s hedged items as at January 2, 2022:
	Change in
		Carrying amount of	value used for		Cash flow
		the hedged item		calculating hedge	hedge reserve
		Assets			Liabilities	ineffectiveness		(AOCI)
Cash flow hedges:
Foreign currency risk:
						Forecast sales	$	— $			—	$	2,554				$	(2,554)
						Forecast expenses		—			—				4	(4)
Commodity risk:
						Forecast purchases		—			—		64,813					(64,813)
Interest rate risk:
						Forecast interest payments		—			—		(2,562)	2,562
							$	— $			—	$	64,809				$	(64,809)
No ineffectiveness was recognized in net earnings as the change in value of the hedging instrument used for calculating ineffectiveness was the same or smal er as the change in value of the hedged items used for calculating the ineffectiveness.
(c) Financial expenses, net:
									2022	2021
Interest expense on financial liabilities recorded at amortized cost (1)				$	25,619 $		14,923
Bank and other financial charges					10,524		8,823
Interest accretion on discounted lease obligations					3,097		2,650
Interest accretion on discounted provisions									47	153
Foreign exchange (gain) loss					(2,330)		782
				$	36,957 $		27,331
(1) Net of capitalized borrowing costs of $2.3 mil ion (2021 - $1.6 mil ion).
				GILDAN 2022 REPORT TO SHAREHOLDERS 101

				NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
15. FINANCIAL INSTRUMENTS (continued):
(d) Hedging components of other comprehensive income (“OCI”):
	2022	2021
Net gain (loss) on derivatives designated as cash flow hedges: Foreign currency risk
			$	10,965 $	3,599
Commodity price risk				46,056	83,130
Interest rate risk				18,628	8,203
Income taxes				(110)	(36)
Amounts reclassified from OCI to inventory, related to commodity
price risk				(114,989)	(22,515)
Amounts reclassified from OCI to net earnings, related to foreign currency risk,
commodity risk, and interest rate risk, and included in: Net sales
				(11,904)	3,326
Cost of sales				22	—
Sel ing, general and administrative expenses				316	(1,992)
Financial expenses, net				(4,100)	146
Income taxes				152	(14)
Other comprehensive (loss) income			$	(54,964) $	73,847
The change in the time value element of option and swap contracts designated as cash flow hedges to reduce the exposure in movements of commodity prices was not significant for the years ended January 1, 2023 and January 2, 2022. The change in the forward element of derivatives designated as cash flow hedges to reduce foreign currency risk was not significant for the years ended January 1, 2023 and January 2, 2022.
Approximately $1.4 mil ion of net gains presented in accumulated other comprehensive income as at January 1, 2023 are expected to be reclassified to inventory or net earnings within the next twelve months.
			GILDAN 2022 REPORT TO SHAREHOLDERS 102

							NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
16. SHARE-BASED COMPENSATION:
The Company’s Long-Term Incentive Plan (the "LTIP") includes stock options, stock appreciation rights ('SARs'), and restricted share units. The LTIP al ows the Board of Directors to grant stock options, SARs, dilutive restricted share units ("Treasury RSUs"), and non-dilutive restricted share units ("non-Treasury RSUs") to officers and other key employees of the Company and its subsidiaries. The number of common shares that are issuable pursuant to the exercise of stock options and the vesting of Treasury RSUs for the LTIP is fixed at 12,000,632. As at January 1, 2023, 83,545 common shares remained authorized for future issuance under this plan.
The exercise price payable for each common share covered by a stock option or SARs is determined by the Board of Directors at the date of the grant, but may not be less than the closing price of the common shares of the Company on the trading day immediately preceding the effective date of the grant. Most stock options vest equal y beginning on the second, third, fourth, and fifth anniversary of the grant date. Stock options granted in fiscal 2020 al vest on the third anniversary of the grant date, subject to performance vesting conditions in some cases. SARs granted in fiscal 2020 vest on the third anniversary of the grant date, and al are subject to performance vesting conditions.
Holders of Treasury RSUs and non-Treasury RSUs are entitled to dividends declared by the Company which are recognized in the form of additional equity awards equivalent in value to the dividends paid on common shares. The vesting conditions of the additional equity awards are subject to the same performance objectives and other terms and conditions as the underlying equity awards. The additional awards related to outstanding Treasury RSUs and non-Treasury RSUs expected to be settled in common shares are credited to contributed surplus when the dividends are declared.
(a) Stock options:
Outstanding stock options were as fol ows:
Stock options issued in Canadian dol ars and to be exercised on the TSX:
		Weighted exercise
	Number		price (CA$)
Stock options outstanding, January 3, 2021					1,463	$			36.33
Changes in outstanding stock options:
						Exercised		(227)		33.48
Stock options outstanding, January 2, 2022					1,236				36.85
Changes in outstanding stock options:
						Exercised		(490)		37.35
Stock options outstanding, January 1, 2023					746	$			36.52
Stock options issued in U.S. dol ars and to be exercised on the NYSE:
		Weighted exercise
	Number		price (US$)
Stock options outstanding, January 3, 2021					2,056	$			27.27
Changes in outstanding stock options:
						Forfeited		(68)		29.01
Stock options outstanding, January 2, 2022					1,988				27.21
Changes in outstanding stock options:
						Granted		—		—
						Forfeited		—		—
Stock options outstanding, January 1, 2023					1,988	$			27.21
				GILDAN 2022 REPORT TO SHAREHOLDERS 103

			NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
16. SHARE-BASED COMPENSATION (continued):
(a) Stock options (continued):
As at January 1, 2023, 745,902 outstanding options issued in Canadian dol ars to be exercised on the TSX were exercisable at the weighted average exercise price of CA$36.52 (January 2, 2022 - 1,235,845 options at CA$36.85), and 601,186 outstanding options issued in U.S. dol ars and to be exercised on the NYSE, were exercisable at the weighted average exercise price of US$29.01 (January 2, 2022 - 433,962 options at US$29.01).
For stock options exercised during fiscal 2022, the weighted average share price at the date of exercise on the TSX was CA$39.02 (2021 - CA$48.12), and there were no stock options exercised on NYSE during fiscal 2022 (2021 - CA$40.58).
The fol owing table summarizes information about stock options issued and outstanding and exercisable at January 1, 2023:
	Options issued and outstanding	Options exercisable
			Remaining
Exercise prices	Number			contractual life (yrs)	Number
CA$33.01		463					1	463
CA$42.27		283					3	283
		746				746
US$20.77		537					5		—
US$29.01		601					2	601
US$30.00		850					5		—
		2,734				1,347
The compensation expense related to stock options included in operating income for fiscal 2022 was $2.5 mil ion (2021 - $2.8 mil ion), and the counterpart has been recorded as contributed surplus. When the underlying shares are issued to the employees, the amounts previously credited to contributed surplus are transferred to share capital.
			GILDAN 2022 REPORT TO SHAREHOLDERS 104

						NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
16. SHARE-BASED COMPENSATION (continued):
(b) Stock appreciation rights ("SARs"):
As at January 1, 2023, 824,406 SARs, at the weighted average exercise price of US$30, remained outstanding with a remaining contractual life of 1 year. Based on the Black-Scholes option pricing model, the grant date weighted average fair value of options granted during 2020 was $5.60. None of the outstanding SARs were exercisable as at January 1, 2023. The compensation expense related to SARs included in operating income for fiscal 2022 was $1.5 mil ion (2021 - $1.5 mil ion), and the counterpart has been recorded as contributed surplus.
(c) Restricted share units:
A Treasury RSU represents the right of an individual to receive one common share on the vesting date without any monetary consideration being paid to the Company. Al Treasury RSUs awarded to date vest within a five-year vesting period. The vesting of at least 50% of each Treasury RSU grant is contingent on the achievement of performance conditions that are based on the Company’s average return on assets performance for the period as compared to the S&P/TSX Capped Consumer Discretionary Index, excluding income trusts.
Outstanding Treasury RSUs were as fol ows:
		Weighted average
	Number	fair value per unit
Treasury RSUs outstanding, January 3, 2021				43	$		30.47
Changes in outstanding Treasury RSUs:
					Granted		5	36.45
					Granted for dividends declared		1	37.93
					Settled through the issuance of common shares		(5)	29.68
					Forfeited		(21)	29.95
Treasury RSUs outstanding, January 2, 2022				23			32.55
Changes in outstanding Treasury RSUs:
					Granted		48	34.67
					Granted for dividends declared		2	30.48
Treasury RSUs outstanding, January 1, 2023				73	$		33.91
As at January 1, 2023 and January 2, 2022, none of the outstanding Treasury RSUs vested.
The compensation expense related to Treasury RSUs included in operating income for fiscal 2022 was an expense of $0.4 mil ion (2021 - $0.2 mil ion recovery), and the counterpart has been recorded as contributed surplus. When the underlying shares are issued to the employees, the amounts previously credited to contributed surplus are transferred to share capital.
			GILDAN 2022 REPORT TO SHAREHOLDERS 105

						NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
16. SHARE-BASED COMPENSATION (continued):
(c) Restricted share units (continued):
Outstanding non-Treasury RSUs were as fol ows:
		Weighted average
	Number	fair value per unit
Non-Treasury RSUs outstanding, January 3, 2021				1,877	$		29.38
Changes in outstanding non-Treasury RSUs:
					Granted		733	30.38
					Granted for dividends declared		25	37.69
					Settled - common shares		(127)	25.14
					Settled - payment of withholding taxes		(70)	25.48
					Forfeited		(492)	32.46
Non-Treasury RSUs outstanding, January 2, 2022				1,946			29.50
Changes in outstanding non-Treasury RSUs:
					Granted		672	38.28
					Granted for dividends declared		47	30.79
					Settled - common shares		(229)	30.69
					Settled - payment of withholding taxes		(146)	31.30
					Forfeited		(201)	34.40
Non-Treasury RSUs outstanding, January 1, 2023				2,089	$		31.63
Non-Treasury RSUs have the same features as Treasury RSUs, except that their vesting period is a maximum of three years and they can be settled in cash based on the Company’s share price on the vesting date, or through the delivery of common shares purchased on the open market, at the Company's option. Non-Treasury RSUs are settled in common shares purchased on the open market, and to the extent that the Company has an obligation under tax laws to withhold an amount for an employee’s tax obligation associated with the share-based payment the Company settles non-Treasury RSUs on a net basis.
The outstanding non-Treasury RSUs awarded to executive officers prior to fiscal 2022 have vesting conditions that are dependent upon the attainment of strategic performance objectives which are set based on the Company’s long-term strategic plan. The outstanding non-Treasury RSUs awarded to executive officers in fiscal 2022 have vesting conditions that are dependent upon the financial performance and share price of the Company relative to a benchmark group of North American publicly listed companies. In addition, up to two times the actual number of non-Treasury RSUs awarded can vest if exceptional financial performance is achieved. As at January 1, 2023 and January 2, 2022, none of the outstanding non-Treasury RSUs were vested.
The compensation cost related to non-Treasury RSUs included in operating income for fiscal 2022 was an expense of $27.8 mil ion (2021 - $33.3 mil ion), and the counterpart has been recorded as contributed surplus. When the underlying common shares are delivered to employees for settlement upon vesting, the amounts previously credited to contributed surplus are transferred to share capital.
			GILDAN 2022 REPORT TO SHAREHOLDERS 106

				NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
16. SHARE-BASED COMPENSATION (continued):
(d) Deferred share unit plan:
The Company has a deferred share unit plan for independent members of the Company’s Board of Directors who must receive at least 50% of their annual board retainers in the form of deferred share units ("DSUs"). The value of these DSUs is based on the Company’s share price at the time of payment of the retainers or fees. Holders of deferred share units are entitled to dividends declared by the Company which are recognized in the form of additional awards equivalent in value to the dividends paid on common shares. DSUs granted under the plan wil be redeemable and the value thereof payable in cash only after the director ceases to act as a director of the Company. As at January 1, 2023, there were 385,403 (January 2, 2022 - 313,271) DSUs outstanding at a value of $10.6 mil ion (January 2, 2022 - $13.3 mil ion). This amount is included in accounts payable and accrued liabilities based on a fair value per deferred share unit of $27.40 (January 2, 2022 - $42.39). The DSU obligation is adjusted each quarter based on the market value of the Company’s common shares. The Company includes the cost of the DSU plan in sel ing, general and administrative expenses, which for fiscal 2022 was $2.5 mil ion (2021 - $2.5 mil ion).
Changes in outstanding DSUs were as fol ows:
	2022	2021
DSUs outstanding, beginning of fiscal year				313	301
Granted				82	58
Granted for dividends declared				7	4
Redeemed				(17)	(50)
DSUs outstanding, end of fiscal year				385	313
(e) Employee share purchase plans:
The Company has employee share purchase plans which al ow eligible employees to authorize payrol deductions of up to 10% of their salary to purchase common shares of the Company at a price of 90% of the then current share price as defined in the plans from Treasury. Employees purchasing shares under the plans subsequent to January 1, 2008 must hold the shares for a minimum of two years. The Company has reserved 5,000,000 common shares for issuance under the plans. As at January 1, 2023, 4,431,093 common shares remained authorized for future issuance under the plans. Included as compensation costs in sel ing, general and administrative expenses is $0.1 mil ion (2021 - $0.1 mil ion) relating to the employee share purchase plans.
17. SUPPLEMENTARY INFORMATION RELATING TO THE NATURE OF EXPENSES:
(a) Selling, general and administrative expenses:
	2022	2021
Sel ing expenses			$	78,520 $	68,591
Administrative expenses				144,925	147,260
Distribution expenses				100,663	98,320
			$	324,108 $	314,171
(b) Employee benefit expenses:
	2022	2021
Salaries, wages and other short-term employee benefits			$	631,619 $	501,036
Share-based payments				32,401	37,660
Post-employment benefits				33,608	28,085
			$	697,628 $	566,781
			GILDAN 2022 REPORT TO SHAREHOLDERS 107

		NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
17. SUPPLEMENTARY INFORMATION RELATING TO THE NATURE OF EXPENSES (continued):
(c) Cost of sales:
Included in cost of sales for the year ended January 1, 2023 are the fol owing items:
•	An expense of $19.7 mil ion related to the write-down of inventory to net realizable value was included in cost of sales.
•	Net insurance gains of $25.9 mil ion, related to the two hurricanes which occurred in Central America in November 2020. The net insurance gains reflected costs of $7.0 mil ion (mainly attributable to equipment repairs and other costs and charges) which were more than offset by related accrued insurance recoveries of $32.9 mil ion. The insurance gains primarily relate to accrued insurance recoveries at replacement cost value for damaged equipment in excess of the write-off of the net book value of property plant and equipment.
	Since November 2020, the Company has recognized $245.7 mil ion of accrued insurance recoveries, of which $235.3 mil ion has been received as an advance ($50.0 mil ion in December 2020, $50.0 mil ion in March 2021, $50.0 mil ion in June 2021, $50.0 mil ion in September 2021 and $35.3 mil ion in December 2022), of which receipts of $12.2 mil ion are included in cash flow from operating activities and $23.1 mil ion included in cash flows from investing activities for the year ended January 1, 2023. As at January 1, 2023, $10.2 mil ion of insurance recoveries receivable are recorded in prepaid expenses, deposits and other current assets in the consolidated statement of financial position.
	The Company recognizes insurance recoveries for items that it has an unconditional contractual right to receive. The Company expects to recognize additional insurance recoveries as the insurance claim process progresses.
Included in cost of sales for the year ended January 2, 2022 are the fol owing items:
	•	A reduction of cost of sales related to pandemic government assistance for users of U.S. cotton of $18.3 mil ion.
	•	Net insurance gains of $46.0 mil ion, related to the two hurricanes which occurred in Central America in November 2020. The net insurance gain reflected costs of $54.7 mil ion, (mainly attributable to equipment repairs, salary and benefits continuation for idle employees, and other costs and charges), which were more than offset by related accrued insurance recoveries of $100.7 mil ion. The insurance gains primarily relate to accrued insurance recoveries at replacement cost value for damaged equipment in excess of the write-off of the net book value of property plant and equipment.
	•	Charges of $4.2 mil ion related to the Company's strategic initiatives to significantly reduce its product line SKU count.
	•	A write-down of production equipment and other assets relating to discontinued SKUs of $4.6 mil ion.
(d) Government assistance:
During the year ended January 1, 2023 an amount of $18.1 mil ion (2021 - $34.1 mil ion) was recognized in cost of sales in the consolidated statement of earnings and comprehensive income relating to government assistance for production costs. The $34.1 mil ion for the year ended January 2, 2022 included a COVID relief stimulus payment of $18.3 mil ion for users of U.S. cotton.
		GILDAN 2022 REPORT TO SHAREHOLDERS 108

			NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
18. RESTRUCTURING AND ACQUISITION-RELATED COSTS:
Restructuring and acquisition-related costs are presented in the fol owing table, and are comprised of costs directly related to significant exit activities, including the closure of business locations or the relocation of business activities, significant changes in management structure, as wel as transaction, exit, and integration costs incurred pursuant to business acquisitions.
	2022	2021
Employee termination and benefit costs	$	971 $	251
Exit, relocation and other costs	2,179 3,312
Net (gain) loss on disposal, write-downs and accelerated depreciation of property, plant and
equipment, right-of-use assets and computer software related to exit activities	(3,259) 3,136
Acquisition-related transaction costs		588 1,526
	$	479 $ 8,225
Restructuring and acquisition-related costs in fiscal 2022 related to the fol owing: $4.8 mil ion for the closure of a yarn-spinning plant in the U.S, $2.6 mil ion in accelerated depreciation of right-of-use assets relating to facilities no longer in use, $0.6 mil ion in employee termination and benefit costs related to the closure of a distribution center in the U.S., as wel $1.9 mil ion related to the completion of previously initiated restructuring activities, partly offset by a gain of $6.0 mil ion on business dispositions (refer to note 5 of the consolidated financial statements), and a gain of $3.4 mil ion on the sale of a former manufacturing facility in Mexico.
Restructuring and acquisition-related costs in fiscal 2021 related to the fol owing: $4.1 mil ion for post-closure costs relating to the Company's former textile manufacturing and sewing operations in Mexico; $2.0 mil ion for yarn-spinning plant in the U.S., that was closed in 2020, including a lease exit charge; $1.5 mil ion in transaction costs incurred in connection with the acquisition of Frontier Yarns; and $0.6 mil ion in other costs, to complete restructuring activities that were initiated in prior years.
			GILDAN 2022 REPORT TO SHAREHOLDERS 109

							NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
19. INCOME TAXES:
The income tax provision differs from the amount computed by applying the combined Canadian federal and provincial tax rates to earnings before income taxes. The reasons for the difference and the related tax effects are as fol ows:
	2022	2021
Earnings before income taxes			$	566,428	$	624,558
Applicable statutory tax rate	26.5 %	26.5 %
Income taxes at applicable statutory rate				150,103		165,508
Increase (decrease) in income taxes resulting from:
Effect of different tax rates and additional income taxes in other jurisdictions				(132,436)			(157,321)
Income tax and other adjustments related to prior taxation years				321					73
Recognition of previously de-recognized tax benefits related to tax losses and
temporary differences				(9,938)					(8,593)
Non-recognition of tax benefits related to tax losses and temporary differences				13,151					11,035
Effect of non-deductible expenses and other				3,687					6,673
Total income tax expense			$	24,888				$	17,375
Average effective tax rate	4.4 %	2.8 %
The Company’s applicable statutory tax rate is the Canadian combined rate applicable in the jurisdictions in which the Company operates.
The details of income tax expense are as fol ows:
	2022	2021
Current income taxes, includes a recovery of $1,283 (2021 - $1,061) relating to prior
taxation years			$	25,039 $	18,340
Deferred income taxes:
Origination and reversal of temporary differences				(4,968)	(4,541)
Recognition of previously de-recognized tax benefits related to tax losses and
temporary differences				(9,938)	(8,593)
Non-recognition of tax benefits related to tax losses and temporary differences				13,151	11,035
Adjustments relating to prior taxation years				1,604	1,134
				(151)	(965)
Total income tax expense			$	24,888 $	17,375
In fiscal 2022, the Company re-recognized $9.9 mil ion (2021 - $8.6 mil ion) of previously de-recognized (in fiscal 2017 pursuant to the organizational realignment plan) deferred income tax assets in the U.S. relating to deferred income tax assets that are now more likely than not to be recovered.
			GILDAN 2022 REPORT TO SHAREHOLDERS 110

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
19. INCOME TAXES (continued):
Significant components of the Company’s deferred income tax assets and liabilities relate to the fol owing temporary differences and unused tax losses:
	January 1,		January 2,
		2023		2022
Deferred income tax assets:
Non-capital losses	$ 111,792 $ 102,138
Non-deductible reserves and accruals		14,837		26,304
Property, plant and equipment and Right-of-use assets		19,761		16,434
Intangible assets		3,427	2,537
Other items		10,189		7,730
		160,006		155,143
Unrecognized deferred income tax assets		(105,658)		(102,749)
Deferred income tax assets	$	54,348 $		52,394
Deferred income tax liabilities:
Property, plant and equipment	$	(38,348) $		(34,668)
Deferred income tax liabilities	$	(38,348) $		(34,668)
Deferred income taxes	$	16,000 $		17,726
The details of changes to deferred income tax assets and liabilities were as fol ows:
		2022		2021
Balance, beginning of fiscal year, net	$	17,726 $		17,689
Recognized in the statements of earnings:
Non-capital losses		10,133		3,462
Non-deductible reserves and accruals		(11,218)		(1,944)
Property, plant and equipment		797	(4,909)
Intangible assets		888	6,425
Other		2,459		274
Unrecognized deferred income tax assets		(2,908)		(2,343)
		151		965
Business acquisitions		(1,754)			(979)
Other		(123)		51
Balance, end of fiscal year, net	$	16,000 $		17,726
As at January 1, 2023, the Company has tax credits, capital and non-capital loss carryforwards, and other deductible temporary differences available to reduce future taxable income for tax purposes representing a tax benefit of approximately $105.7 mil ion, for which no deferred tax asset has been recognized (January 2, 2022 - $102.7 mil ion), because the criteria for recognition of the tax asset was not met. The tax credits and capital and non-capital loss carryforwards expire between 2027 and 2042. The recognized deferred tax asset related to loss carryforwards is supported by projections of future profitability of the Company.
The Company has not recognized a deferred income tax liability for the undistributed profits of subsidiaries operating in foreign jurisdictions, as the Company currently has no intention to repatriate these profits. If expectations or intentions change in the future, the Company may be subject to an additional tax liability upon distribution of these earnings in the form of dividends or otherwise. As at January 1, 2023, a deferred income tax liability of approximately $67 mil ion would result from the recognition of the taxable temporary differences of approximately $627 mil ion.
					GILDAN 2022 REPORT TO SHAREHOLDERS 111

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
20. EARNINGS PER SHARE:
Reconciliation between basic and diluted earnings per share is as fol ows:
	2022	2021
Net earnings - basic and diluted			$	541,540 $	607,183
Basic earnings per share:
Basic weighted average number of common shares outstanding				184,128	197,014
Basic earnings per share			$	2.94 $	3.08
Diluted earnings per share:
Basic weighted average number of common shares outstanding				184,128	197,014
Plus dilutive impact of stock options, Treasury RSUs, and common
				shares held in trust		404	581
Diluted weighted average number of common shares outstanding				184,532	197,595
Diluted earnings per share			$	2.93 $	3.07
Excluded from the above calculation for the year ended January 1, 2023 are 282,737 stock options (2021 - nil) and 25,614 Treasury RSUs (2021 - nil) which were deemed to be anti-dilutive.
21. DEPRECIATION AND AMORTIZATION:
	2022	2021
Depreciation of property, plant and equipment (note 9)			$	102,314 $	92,176
Depreciation of right-of-use assets (note 10)				14,777	13,973
Adjustment for the variation of depreciation included in inventories at the beginning
and end of the year				(11,317)	11,177
Amortization of intangible assets, excluding software (note 11)				13,755	12,818
Amortization of software (note 11)				5,397	5,258
Depreciation and amortization included in net earnings			$	124,926 $	135,402
			GILDAN 2022 REPORT TO SHAREHOLDERS 112

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
22. SUPPLEMENTAL CASH FLOW DISCLOSURE:
(a) Adjustments to reconcile net earnings to cash flows from operating activities - other items:
	2022	2021
Deferred income taxes (note 19)			$	(151) $	(965)
Unrealized net (gain) loss on foreign exchange and financial derivatives				(352)	(5,958)
Other non-current assets				1,654	2,246
Other non-current liabilities				6,989	2,653
			$	8,140 $	(2,024)

(b) Variations in non-cash transactions:
	2022	2021
Net additions to property, plant and equipment and intangible assets included in
				accounts payable and accrued liabilities	$	1,522 $	4,641
Proceeds on disposal of property, plant and equipment and computer software
				included in other current assets		157	—
Additions to right-of-use assets included in lease obligations				2,960	3,504
Shares repurchases for cancel ation included in accounts payable and accrued
				liabilities		(5,299)	—
Non-cash ascribed value credited to share capital from shares issued or distributed
				pursuant to vesting of restricted share units and exercise of stock options		8,996	4,515
Deferred compensation credited to contributed surplus				(2,110)	(2,075)
Non-cash ascribed value credited to contributed surplus for dividends attributed to
				restricted share units		1,497	943

(c) Changes in non-cash working capital balances:
	2022	2021
Trade accounts receivable			$	77,940 $	(135,103)
Income taxes				(1,571)	12,577
Inventories				(448,838)	(33,744)
Prepaid expenses, deposits and other current assets				29,915	(18,964)
Accounts payable and accrued liabilities				35,460	78,495
			$	(307,094) $	(96,739)

			GILDAN 2022 REPORT TO SHAREHOLDERS 113

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
23. RELATED PARTY TRANSACTIONS:
Key management personnel compensation:
Key management personnel includes those individuals that have authority and responsibility for planning, directing and control ing the activities of the Company, directly or indirectly, and is comprised of the members of the executive management team and the Board of Directors. The amount for compensation expense recognized in net earnings for key management personnel, including amounts for an executive who retired during fiscal 2021, was as fol ows:
	2022	2021
Short-term employee benefits			$	7,894 $	12,296
Post-employment benefits				181	907
Share-based payments				24,826	30,460
			$	32,901 $	43,663
The amounts included in accounts payable and accrued liabilities for share-based compensation awards to key management personnel were as fol ows:
	January 1,			January 2,
	2023	2022
DSUs	$ 10,560 $ 13,280
Other:
During fiscal 2022, the Company incurred expenses for aircraft and other services of $1.9 mil ion (2021 - $1.5 mil ion), with companies control ed by the President and Chief Executive Officer of the Company. The payments made are in accordance with the terms of the agreement established and agreed to by the related parties. As at January 1, 2023, the amount in accounts payable and accrued liabilities related to the airplane usage and other services was $0.1 mil ion (January 2, 2022 - $0.3 mil ion).
On June 23, 2021, the aircraft agreement was amended with an effective date of January 1, 2021 to incorporate a minimum usage fee per year, which is calculated as the average usage in the two preceding fiscal years, excluding the years 2020 and 2021, multiplied by the hourly fee. As at January 1, 2023, the Company has a commitment of $1.4 mil ion under this amended agreement, which relates to minimum usage fees for fiscal 2023.
24. COMMITMENTS, GUARANTEES AND CONTINGENT LIABILITIES:
(a) Claims and litigation:
The Company is a party to claims and litigation arising in the normal course of operations. The Company does not expect the resolution of these matters to have a material adverse effect on the financial position or results of operations of the Company.
(b) Guarantees:
The Company, and some of its subsidiaries, have granted financial guarantees, irrevocable standby letters of credit, and surety bonds to third parties to indemnify them in the event the Company and some of its subsidiaries do not perform their contractual obligations. As at January 1, 2023, the maximum potential liability under these guarantees was $153.0 mil ion (January 2, 2022 - $121.3 mil ion), of which $17.3 mil ion was for surety bonds and $135.7 mil ion was for financial guarantees and standby letters of credit (January 2, 2022 - $10.5 mil ion and $110.8 mil ion, respectively).
As at January 1, 2023, the Company has recorded no liability with respect to these guarantees, as the Company does not expect to make any payments for the aforementioned items.
			GILDAN 2022 REPORT TO SHAREHOLDERS 114

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
25. CAPITAL DISCLOSURES:
The Company’s objective in managing capital is to ensure sufficient liquidity to pursue its organic growth strategy and undertake selective acquisitions, while maintaining a strong credit profile and a capital structure that reflects a target ratio of financial leverage as noted below.
The Company’s capital is composed of net debt and shareholders’ equity. Net debt consists of interest-bearing debt less cash and cash equivalents. The Company’s use of capital is to finance working capital requirements, capital expenditures, business acquisition, payment of dividends, as wel as share repurchases. The Company currently funds these requirements out of its internal y-generated cash flows and with funds drawn from its long-term debt facilities.
The primary measure used by the Company to monitor its financial leverage is its net debt leverage ratio. The Company’s net debt leverage ratio is defined as the ratio of net debt to adjusted EBITDA for the trailing twelve months, on a pro-forma basis to reflect business acquisitions made during the trailing twelve month period, as if they had occurred at the beginning of the trailing twelve month period. Adjusted EBITDA is calculated as earnings before financial expenses, income taxes, and depreciation and amortization, and excludes the impact of restructuring and acquisition-related costs. Adjusted EBITDA also excludes impairment of goodwil and intangible assets and reversal of impairments on intangible assets, net insurance gains related to the two hurricanes which impacted the Company’s operations in Central America, the discontinuance of PPE SKUs, the impact of the Company's strategic initiative to significantly reduce its retail product line SKU count which the Company began implementing in the fourth quarter of fiscal 2020, and the impact of adjustments related to the Company’s decision in the fourth quarter of fiscal 2019 to implement a strategic initiative to significantly reduce its imprintables product line SKU count, by exiting al ship to-the-piece activities and discontinuing overlapping and less productive styles and SKUs between brands. The Company has set a fiscal year-end net debt leverage target ratio of one to two times adjusted EBITDA. As at January 1, 2023, the Company’s net debt leverage ratio was 1.1 times (January 2, 2022 - 0.7 times).
In order to maintain or adjust its capital structure, the Company, upon approval from its Board of Directors, may issue or repay long-term debt, issue shares, repurchase shares, pay dividends or undertake other activities as deemed appropriate under the specific circumstances. The Board of Directors wil consider several factors when deciding to declare quarterly cash dividends or approve share repurchase programs, including the Company’s present and future earnings, cash flows, capital requirements and present and/or future regulatory and legal restrictions. There can be no assurance as to the declaration of future quarterly cash dividends. On February 22, 2022, the Board of Directors approved a 10% increase in the amount of the current quarterly dividend and declared a cash dividend of $0.169 per share. The Company paid dividends of $123.8 mil ion during the year ended January 1, 2023, representing dividends declared per common share of $0.676. On February 21, 2023, the Board of Directors approved a 10% increase in the amount of the current quarterly dividend and declared a cash dividend of $0.186 per share, on al of the issued and outstanding common shares of the Company, rateably and proportionately, to the holders of record on March 14, 2023. The Company repurchased for cancel ation a total of 13,096,866 common shares under its NCIB programs for a total cost of $443.9 mil ion during the year ended January 1, 2023.
The Company is not subject to any capital requirements imposed by a regulator.
	GILDAN 2022 REPORT TO SHAREHOLDERS 115

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT:
Due to the nature of the activities that the Company carries out and as a result of holding financial instruments, the Company is exposed to risks arising from financial instruments, including credit risk, liquidity risk, foreign currency risk, interest rate risk, commodity price risk, as wel as risks arising from changes in the price of its common shares under the Company's share-based compensation plans.
The Company may periodical y use derivative financial instruments to manage risks related to fluctuations in foreign exchange rates, commodity prices, interest rates, and the market price of its own common shares. The use of derivative financial instruments is governed by the Company’s Financial Risk Management Policy approved by the Board of Directors and is administered by the Financial Risk Management Committee. The Financial Risk Management Policy of the Company stipulates that derivative financial instruments should only be used to hedge or mitigate an existing financial exposure that constitutes a commercial risk to the Company, and if the derivatives are determined to be the most efficient and cost effective means of mitigating the Company’s exposure to liquidity risk, foreign currency risk, and interest rate risk, as wel as risks arising from commodity prices. Hedging limits, as wel as counterparty credit rating and exposure limitations are defined in the Company’s Financial Risk Management Policy, depending on the type of risk that is being mitigated. Derivative financial instruments are not used for speculative purposes.
At the inception of each designated hedging derivative contract, the Company formal y designates and document the hedging relationship and its risk management objective and strategy for undertaking the hedge. Documentation includes identification of the hedging instrument, the hedged item, the nature of the risk being hedged, and how the Company wil assess whether the hedging relationship meets the hedge effectiveness requirements, including its analysis of the sources of hedge ineffectiveness and how they determine the hedge ratio.
Credit risk
Credit risk is the risk of an unexpected loss if a customer or counterparty to a financial instrument fails to meet its contractual obligations and arises primarily from the Company’s trade accounts receivable. The Company may also have credit risk relating to cash and cash equivalents and derivative financial instruments, which it manages by dealing only with highly rated North American and European financial institutions. The Company's credit risk may also be exacerbated during periods of weak general economic and financial conditions. The Company's trade accounts receivable and credit exposure fluctuate throughout the year based on the seasonality of its sales and other factors. The Company’s average trade accounts receivable and credit exposure during an interim reporting period may be significantly higher than the balance at the end of that reporting period. In addition, due to the historical seasonality of the Company’s net sales, the Company’s trade accounts receivable balance as at the end of a calendar year wil typical y be lower than at the end of an interim reporting period.
Under the terms of a receivables purchase agreement, the Company may continuously sel trade accounts receivables of certain designated customers to a third-party financial institution in exchange for a cash payment equal to the face value of the sold trade accounts receivables, less an applicable discount. The Company retains servicing responsibilities, including col ection, for these trade accounts receivables but does not retain any credit risk with respect to any trade accounts receivables that have been sold. Al trade accounts receivables sold under the receivables purchase agreement are removed from the consolidated statements of financial position, as the sale of the trade accounts receivables qualify for de-recognition. The receivables purchase agreement, which al ows for the sale of a maximum of $300 mil ion of accounts receivables at any one time, expires on June 19, 2023, subject to annual extensions.
The Company’s credit risk for trade accounts receivables is concentrated as the majority of its sales are to a relatively smal group of wholesale distributors and mass-market and other retailers. As at January 1, 2023, the Company’s ten largest trade debtors accounted for 72% of trade accounts receivable (2021 - 78%); the largest of which accounted for 23% (2021 - 24%). The Company’s main trade debtors are located in the U.S. The remaining trade accounts receivable balances are dispersed among a larger number of debtors across many geographic areas including the U.S., Canada, Europe, Asia-Pacific, and Latin America.
The Company makes an assessment of whether accounts receivable are col ectable, based on an expected credit loss model which factors in changes in credit quality since the initial recognition of trade accounts receivable based on customer risk categories. Credit quality is assessed by taking into account the financial condition and payment history of the Company's customers, and other factors.
	GILDAN 2022 REPORT TO SHAREHOLDERS 116

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT (continued):
Credit risk (continued)
In determining its al owance for expected credit losses, the Company applies the simplified approach per IFRS 9, Financial Instruments, and calculates expected credit losses based on lifetime expected credit losses. The Company uses a provision matrix, which segregates its customers by their economic characteristics and al ocates expected credit loss rates based on days past due of its trade receivables. Expected credit loss rates are based on the Company’s historical credit loss experience, adjusted for forward-looking factors of the economic environment.
Most of the Company’s customers have been transacting with the Company or its subsidiaries for several years. Certain wholesale distributors are highly leveraged with significant reliance on trade credit terms provided by a few major vendors, including the Company, and third-party debt financing, including bank debt secured with trade accounts receivable and inventory pledged as col ateral. The financial leverage of these customers may limit or prevent their ability to refinance existing indebtedness or to obtain additional financing and could affect their ability to comply with restrictive debt covenants and meet other obligations. The profile and credit quality of the Company’s mass-market and other retailer customers vary significantly.
The Company’s extension of credit to customers involves considerable judgment and is based on an evaluation of each customer’s financial condition and payment history. The Company has established various internal controls designed to mitigate credit risk, including a dedicated credit function which recommends customer credit limits and payment terms that are reviewed and approved on a quarterly basis by senior management at the Company’s primary sales offices in Christ Church, Barbados. Where available, the Company’s credit departments periodical y review external ratings and customer financial statements and, in some cases, obtain bank and other references. New customers are subject to a specific validation and pre-approval process. From time to time, where circumstances warrant, the Company wil temporarily transact with customers on a prepayment basis. While the Company’s credit controls and processes have been effective in mitigating credit risk, these controls cannot eliminate credit risk in its entirety and there can be no assurance that these controls wil continue to be effective or that the Company’s historical credit loss experience wil continue.
The Company’s exposure to credit risk for trade accounts receivable by geographic area was as fol ows as at:
	January 1,		January 2,
		2023		2022
Trade accounts receivable by geographic area:
United States	$	198,949 $		296,100
Canada		13,279		16,954
Europe and other		36,557		16,913
Total trade accounts receivable	$	248,785 $		329,967
The aging of trade accounts receivable balances was as fol ows as at:
	January 1,		January 2,
		2023		2022
Not past due	$	239,218 $		318,528
Past due 0-30 days		10,842		9,352
Past due 31-60 days		3,907	3,667
Past due 61-120 days		6,837	2,903
Past due over 121 days		3,375	9,221
Trade accounts receivable		264,179		343,671
Less al owance for expected credit losses		(15,394)		(13,704)
Total trade accounts receivable	$	248,785 $		329,967
					GILDAN 2022 REPORT TO SHAREHOLDERS 117

			NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT (continued):
Liquidity risk
Liquidity risk is defined as the potential risk that the Company wil not be able to meet its financial obligations as they fal due.
The Company manages its liquidity risk through the management of its capital structure and financial leverage, as outlined in note 25 to these consolidated financial statements. In addition, the Company manages this risk by continuously monitoring actual and projected cash flows, taking into account the seasonality of its sales and cash receipts and the expected timing of capital expenditures.
In managing its liquidity risk, the Company relies on cash resources, debt, and cash flows generated from operations to satisfy its financing requirements. The Company may also require access to capital markets to support its operations as wel as to achieve its strategic plans. Any impediments to the Company's ability to continue to meet the covenants and conditions contained in its long-term debt agreements as wel as the Company's ability to access capital markets, the failure of a financial institution participating in its revolving long-term bank credit facilities, or an adverse perception in capital markets of the Company's financial condition or prospects could have a material impact on its future financing capability. In addition, the Company's access to capital markets and to financing at reasonable terms and interest rates could be influenced by the economic and credit market environment, including a potential prolonged economic downturn and recessions resulting from the unprecedented nature of the COVID-19 pandemic.
The fol owing tables present a maturity analysis based on contractual maturity date of the Company's financial liabilities. Al commitments have been reflected in the consolidated statements of financial position except for purchase obligations, as wel as minimum royalty payments, which are included in the table of contractual obligations below. The amounts are the contractual undiscounted cash flows.
	Carrying	Contractual Less than	Between 1	Between 4	More than
(in $ mil ions)	amount	cash flows				1 year and 3 years and 5 years	5 years
Accounts payable and accrued liabilities	471.2						471.2	471.2		—	—	—
Long-term debt		930.0						930.0	150.0		—	780.0			—
Purchase and other obligations											—	598.5	335.8	132.5		87.7	42.5
Lease obligations		94.0						114.9	19.3		29.2	22.8	43.6
Total contractual obligations	1,495.2	2,114.6				976.3	161.7	890.5						86.1
As disclosed in note 24, the Company has granted financial guarantees, irrevocable standby letters of credit, and surety bonds to third parties to indemnify them in the event the Company and some of its subsidiaries do not perform their contractual obligations. As at January 1, 2023, the maximum potential liability under these guarantees was $153.0 mil ion, of which $17.3 mil ion was for surety bonds and $135.7 mil ion was for financial guarantees and standby letters of credit.
Foreign currency risk
The majority of the Company’s cash flows and financial assets and liabilities are denominated in U.S. dol ars, which is the Company’s functional and reporting currency. Foreign currency risk is mainly limited to the portion of the Company’s business transactions denominated in currencies other than U.S. dol ars, primarily for sales and distribution expenses for customers outside the U.S., certain equipment purchases, and head office expenses in Canada. The Company’s exposure relates primarily to changes in the U.S. dol ar versus the Canadian dol ar, the Pound sterling, the Euro, the Australian dol ar, the Mexican peso, and the Chinese yuan. For the Company’s foreign currency transactions, fluctuations in the respective exchange rates relative to the U.S. dol ar wil create volatility in the Company’s cash flows, in the reported amounts for sales and SG&A expenses in its consolidated statement of earnings and comprehensive income, and for property, plant and equipment in its consolidated statement of financial position, both on a period-to-period basis and compared with operating budgets and forecasts. Additional earnings variability arises from the translation of monetary assets and liabilities denominated in currencies other than the U.S. dol ar at the rates of exchange at each reporting dates, the impact of which is reported as a foreign exchange gain or loss and included in financial expenses (net) in the statement of earnings and comprehensive income.
			GILDAN 2022 REPORT TO SHAREHOLDERS 118

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

26. FINANCIAL RISK MANAGEMENT (continued):

Foreign currency risk (continued)

The Company also incurs a portion of its manufacturing costs in foreign currencies, primarily payrol costs paid in Honduran Lempiras, Dominican Pesos, Mexican Pesos, Nicaraguan Cordobas, as wel as in Bangladeshi Taka. Significant changes in these currencies relative to the U.S. dol ar exchange rate in the future, could have a significant impact on the Company's operating results.

The Company’s objective in managing its foreign currency risk is to minimize its net exposures to foreign currency cash flows, by transacting with third parties in U.S. dol ars to the maximum extent possible and practical and holding cash and cash equivalents and incurring borrowings in U.S. dol ars. The Company monitors and forecasts the values of net foreign currency cash flows and, from time to time wil authorize the use of derivative financial instruments, such as forward foreign exchange contracts with maturities of up to three years, to economical y hedge a portion of foreign currency cash flows. The Company had forward foreign exchange contracts outstanding as at January 1, 2023, consisting primarily of contracts to sel and buy Canadian dol ars, sel and buy Euros, sel Pounds sterling, sel Australian dol ars, and sel Mexican pesos in exchange for U.S. dol ars. The outstanding contracts and other foreign exchange contracts that were settled during fiscal 2022 were designated as cash flow hedges and qualified for hedge accounting. The underlying risk of the foreign exchange contracts is identical to the hedged risk and, accordingly, the Company has established a ratio of 1:1 for al foreign exchange hedges.

The fol owing tables provide an indication of the Company’s significant foreign currency exposures included in the consolidated statement of financial position as at January 1, 2023 arising from financial instruments:

January 1, 2023

(in U.S. $ mil ions)

CAD

GBP

EUR

AUD

MXN

CNY

BDT

COP

Cash and cash equivalents

4.7 0.7 3.2 1.1 6.7 2.0 14.8 0.2

Trade accounts receivable

13.0 4.6 17.8 4.0 4.1 0.7

—

Prepaid expenses, deposits and other current

assets

1.4 0.3 7.7

— 0.8 0.6 3.1 0.3

Accounts payable and accrued liabilities

(17.2) (0.7) (11.8) (0.8) (2.4) (1.8) (9.2)

—

Based on the Company’s foreign currency exposures arising from financial instruments noted above, and the impact of outstanding derivative financial instruments designated as effective hedging instruments, varying the foreign exchange rates to reflect a 5 percent strengthening of the U.S. dol ar would have (decreased) increased earnings and other comprehensive income as fol ows, assuming that al other variables remained constant:

For the year ended January 1, 2023

(in U.S. $ mil ions)

CAD

GBP

EUR

AUD

MXN

CNY

BDT

COP

Impact on earnings before income taxes

(0.1) (0.2) (0.8) (0.2) (0.5) (0.1) (0.4)

—

Impact on other comprehensive (loss) income before

income taxes

0.6 2.1 1.9 0.4 0.1

—

An assumed 5 percent weakening of the U.S. dol ar during the year ended January 1, 2023 would have had an equal but opposite effect on the above currencies to the amounts shown above, assuming that al other variables remain constant.

GILDAN 2022 REPORT TO SHAREHOLDERS 119

	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT (continued):
Commodity risk
The Company is subject to the commodity risk of cotton prices and cotton price movements, as the majority of its products are made of 100% cotton or blends of cotton and synthetic fibers. The Company is also subject to the risk of fluctuations in the prices of crude oil and petrochemicals as they influence the cost of polyester fibers which are used in many of its products. The Company purchases cotton from third-party merchants, cotton-based yarn from third-party yarn manufacturers, and polyester fibers from third-party polyester manufacturers. The Company assumes the risk of price fluctuations for these purchases. The Company enters into contracts, up to eighteen months in advance of future delivery dates, to establish fixed prices for its cotton and cotton-based yarn purchases and polyester fibers purchases, in order to reduce the effects of fluctuations in the cost of cotton, crude oil, and petrochemicals used in the manufacture of its products. These contracts are not used for trading purposes and are not considered to be financial instruments that would need to be accounted for at fair value in the Company’s consolidated financial statements. Without taking into account the impact of fixed price contracts, a change of $0.01 per pound in the price of cotton would affect the Company’s annual raw material costs by approximately $4.8 mil ion, based on current production levels.
In addition, fluctuations in crude oil or petroleum prices also affect the Company's energy consumption costs and can influence transportation costs and the cost of related items used in its business, including other raw materials the Company uses to manufacture its products such as chemicals, dyestuffs, and trims. The Company general y purchases these raw materials at market prices.
The Company also has the ability to enter into derivative financial instruments, including futures and option contracts, to manage its exposure to movements in commodity prices. Such contracts are accounted for at fair value in these consolidated financial statements in accordance with the accounting standards applicable to financial instruments. During fiscal 2022, the Company entered into commodity derivative contracts as described in note 15. The underlying risk of the commodity derivative contracts is identical to the hedged risk and accordingly, the Company has established a ratio of 1:1 for al commodity derivative hedges. Due to a strong correlation between commodity future contract prices and its purchased costs, the Company did not experience any significant ineffectiveness on its hedges, other than as disclosed in note 15(d).
Interest rate risk
The Company is subject to interest rate risk arising from its $300 mil ion term loan, $100 mil ion of its unsecured notes payable, and amounts drawn on its revolving long-term bank credit facilities, al of which bear interest at a variable U.S. interest rate, plus a spread. The spread added to the adjusted Term SOFR is a function of the total net debt to EBITDA ratio.
The Company general y fixes the rates for both adjusted Term SOFR and LIBOR-based borrowings for periods of one to three months. The interest rates on amounts drawn on debt agreements and on any future borrowings wil vary and are unpredictable. Increases in interest rates on new debt issuances may result in a material increase in financial charges.
The Company has the ability to enter into derivative financial instruments that would effectively fix its cost of current and future borrowings for an extended period of time. The Company has floating-to-fixed interest rate swaps outstanding to hedge up to $250 mil ion of its floating interest rate exposure on a designated portion of certain long-term debt agreements. The interest rate swap contracts are designated as cash flow hedges and qualify for hedge accounting. Refer to note 15(b) for additional information.
As discussed in note 12 of these consolidated financial statements, the Company amended its revolving facility and term loan facility to replace LIBOR references with Term Secured Overnight Financing Rate (‘ Term SOFR’ ). The notes purchase agreement was also amended to include LIBOR fal back provisions to replace LIBOR with adjusted term SOFR, adjusted daily simple SOFR or any relevant alternate rate selected by the note holders and the Company upon a benchmark transition event or early opt-in election. In addition, the Company and its counterparties under interest rate swap agreements are in the process of negotiating the substitution of reference rates in such agreements.
	GILDAN 2022 REPORT TO SHAREHOLDERS 120

						NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
26. FINANCIAL RISK MANAGEMENT (continued):
Interest rate risk (continued):
In July 2017, the United Kingdom’s Financial Conduct Authority (FCA), which regulates LIBOR, announced that it intends to stop persuading or compel ing banks to submit rates for the calculation of LIBOR to the administrator of LIBOR after 2021. In March 2021, the FCA announced that it wil cease the issuance of the EUR, CHF, JPY and GBP LIBOR for al tenors, as wel as the one week and two month USD LIBOR at the end of December 31, 2021. Al other USD LIBOR tenors wil cease at the end of June 30, 2023.
The Company may be subject to disputes or litigation with lenders over the appropriateness or comparability to LIBOR of the substitute reference rates.
Based on the value of interest-bearing financial instruments during the year ended January 1, 2023, an assumed 0.5 percentage point increase in interest rates during such period would have decreased earnings before income taxes by $2.1 mil ion. An assumed 0.5 percentage point decrease in interest rates would have had an equal but opposite effect on earnings before income taxes, assuming that al other variables remain constant.
27. DISAGGREGATION OF REVENUE:
Net sales by major product group were as fol ows:
	2022	2021
Activewear			$	2,762,533 $	2,364,740
Hosiery and underwear				477,949	557,830
			$	3,240,482 $	2,922,570
Net sales were derived from customers located in the fol owing geographic areas:
	2022	2021
United States			$	2,846,810 $	2,526,552
Canada				122,518	114,800
International				271,154	281,218
			$	3,240,482 $	2,922,570
			GILDAN 2022 REPORT TO SHAREHOLDERS 121

					NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
28. ENTITY-WIDE DISCLOSURES:
Property, plant and equipment, right-of-use-assets, intangible assets, and goodwil , are al ocated to geographic areas as fol ows:
	January 1,		January 2,
		2023		2022
United States	$	560,854 $		602,120
Canada		59,604		69,939
Honduras		380,825		346,256
Caribbean		440,511		486,876
Asia-Pacific		223,307		129,926
Other		29,654		32,848
	$	1,694,755 $		1,667,965
Customers accounting for at least 10% of total net sales for the fiscal years ended January 1, 2023 and January 2, 2022 were as fol ows:
	2022			2021
Customer A	18.6 %		15.9 %
Customer B	18.1 %		13.9 %
Customer C	10.7 %		5.9 %
					GILDAN 2022 REPORT TO SHAREHOLDERS 122